Thermodynamic and Kinetic Aspects of Hen Egg White Lysozyme Amyloid Assembly by Miti, Tatiana
University of South Florida
Scholar Commons
Graduate Theses and Dissertations Graduate School
November 2017
Thermodynamic and Kinetic Aspects of Hen Egg
White Lysozyme Amyloid Assembly
Tatiana Miti
University of South Florida, tmiti@mail.usf.edu
Follow this and additional works at: https://scholarcommons.usf.edu/etd
Part of the Biophysics Commons, Other Education Commons, and the Physics Commons
This Dissertation is brought to you for free and open access by the Graduate School at Scholar Commons. It has been accepted for inclusion in
Graduate Theses and Dissertations by an authorized administrator of Scholar Commons. For more information, please contact
scholarcommons@usf.edu.
Scholar Commons Citation
Miti, Tatiana, "Thermodynamic and Kinetic Aspects of Hen Egg White Lysozyme Amyloid Assembly" (2017). Graduate Theses and
Dissertations.
https://scholarcommons.usf.edu/etd/7425
 
 
 
 
 
Thermodynamic and Kinetic Aspects of Hen Egg White Lysozyme Amyloid Assembly 
 
 
 
by 
 
 
 
Tatiana Miti 
 
 
 
 
A dissertation submitted in partial fulfillment 
of the requirements for a degree of 
Doctor of Philosophy 
Department of Physics 
College of Arts and Sciences 
University of South Florida 
 
 
 
Major Professor: Martin Muschol, PhD 
Vladimir Uversky, PhD 
Sagar Pandit, PhD 
Ghanim Ullah, PhD 
Robert Hoy, PhD 
Piyush Koria, PhD 
 
 
Date of Approval: 
June 27, 2017 
 
 
 
Keywords: Phase Diagram, Nucleated Polymerization, Nucleated Conformational Conversion 
 
Copyright © 2017, Tatiana Miti 
 
 
 
 
 
 
 
ACKNOWLEDGMENTS 
 
 I would like to take this opportunity to thank all those who have supported and inspired 
me during my dissertation research. First and foremost, I would like to thank my PhD advisor 
Dr. Martin Muschol for his direction, inspiration, knowledge, and patience. The fortuity to work 
with him during my undergraduate years helped me discover my love for physics and played a 
central role in my decision to continue doctoral research under his guidance. His high ethical and 
quality standards have made me a better experimentalist, and this dissertation work would not 
have been possible without his direction. 
I would also like to thank Dr. Vladimir Uversky for his support throughout my PhD years. His 
advice and insights have helped me to take better decision in both my academic and non-
academic life. I also tank Dr. Leo Breydo for his great help and advice. I thank both Dr. Uversky 
and Breydo for using their equipment and laboratory space in numerous occasions. I am deeply 
grateful Dr. Sagar Pandit and Dr. Robert Hoy for inspiring and helping me to explore the 
theoretical and computational side of biophysics and soft matter.  
 I would like to thank Dr. Piyush Koria for the opportunity to explore both the biological 
and the physical the realm of synthetic peptides. The two years of collaboration have given me 
the opportunity learn new experimental skills and gain knowledge in a different area of 
biophysics. 
 
 
 I thank Dr. Ghanim Ullah for his great help in modeling our amyloid aggregation 
behavior. During our collaboration so far, we gained new insights into the molecular 
mechanisms of amyloid aggregation as well as point out some limitations or unexplored 
experimental approaches.  
 I thank Dr. Garrett Matthews for allowing me to use his AFM and Himanshu Verma for 
training me. 
 I would like to give special thanks to my former lab member, Dr. Shannon Hill, for her 
experimental training, advice, encouragement and friendship during my first years in the 
laboratory. She has been and continues to be a great inspiration for me. 
  I would like to thank my former lab colleague, Mentor Mulaj for collecting a part of 
AFM images presented in this dissertation and also for his support and help in the lab. I would 
like to thank my former lab colleague, Joseph Foley for collecting a part of FTIR images 
presented in this dissertation and also for his kindness, support and help in the lab.  
 I am especially grateful for Chamani Nyangoda and Jeremy Barton, who have become 
great friends and a source of inspiration. The lab would not be the same without your cheerful 
presence! 
 I am thankful for my fellow friends in the physics department, Alan Kramer and Tatiana 
Eggers for their emotional support and encouragement.  
 I am endlessly grateful to my mother and sister for their support, love and patience during 
my university years. They have given me the strength and inspiration to continue despite all 
adversity. 
 
 
 Last but not least, I would like to say thank you to my wonderful husband, Mikalai. He 
has been my best friend, my pillar and my source of optimism and calm during the last five 
years. I could have not done this without him.  
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
i 
 
 
 
 
TABLE OF CONTENTS 
List of Tables  ................................................................................................................................ iii 
 
List of Figures  ............................................................................................................................... iv 
 
Abstract  ......................................................................................................................................... vi 
 
I. Introduction  .................................................................................................................................1 
 I.1 Amyloidosis as Health Care Challenge  .............………………………………………1 
 I.2 Structural Hallmarks of ―Classical‖ Amyloid Fibrils  ....................................................3 
 I.3 Amyloid Aggregation Pathways  ....................................................................................6 
 I.4 Amyloid Aggregation Mechanisms  ...............................................................................7 
 I.5 Amyloid Species Phase Diagram(s) and Their Importance in the Field  .....................10 
 I.6 Motivation and Goals for My Research  ......................................................................12 
 
II. Methods and Experimental Protocols  ......................................................................................14 
 II.1 Materials and Sample Preparation Protocols  .............................................................14 
 II.1.1. Fresh Hen Egg White Lysozyme Sample Preparation  ...............................14 
 II.1.2 Thioflavin T Stock Preparation ....................................................................15 
 II.1.3 Rigid Fibrils and Curvilinear Fibrils Aggregates for Isolation  ...................15 
 II.1.4 Rigid Fibrils Isolation Protocol  ...................................................................16 
 II.1.5 Curvilinear Fibril Decay Experiment  ..........................................................17 
 II.1.6 Determination of Rigid Fibrils Nucleation Lag Periods  .............................17 
II.2 Methods and Measurements Parameters  ....................................................................19 
 II.2.1 Static and Dynamic Light Scattering Kinetics Measurements  ....................20 
 II.2.2 Thioflavin T Fluorescence Monitored Hen Egg White Lysozyme 
 Amyloid Fibril Formation Kinetics  ............................................................20 
 II.2.3 Fourier Transform Infrared Spectroscopy Measurements  ..........................22 
 II.2.4 Atomic Forces Microscopy Imaging  ...........................................................25 
 II.2.5 Circular Dischroism Spectroscopy Measurements  .....................................25 
 II.2.6 Gel Electrophoresis Experiment  ..................................................................26 
 
III. Hen Egg Lysozyme Model  .....................................................................................................27 
 III.1 Hen Egg White Lysozyme General Biophysical Characterization  ...........................27 
 III.2 Hen Egg White Lysozyme Link to Amyloid Diseases  .............................................29 
 
IV. Results .....................................................................................................................................32 
 IV.1 Hen Egg Lysozyme‘s Two Assembly Pathways Kinetics and Aggregates 
 Morphologies  ..................................................................................................................... 32 
ii 
 
 IV.2 Hen Egg Lysozyme Aggregates‘ Structures and Their Time Evolution  .................... 38 
 IV.2.1 Probing Hen Egg Lysozyme Aggregates‘ Structures and Their  
 Time Evolution Using Fourier Transform Infrared Spectroscopy  .............38 
 IV.2.2 Probing Hen Egg Lysozyme Aggregates‘ Structures Time  
 Evolution Using Thioflavin T  .......................................................................... 41 
 IV.2.3 Investigation of Hydrolysis Effects on Thioflavin T Aggregate - 
 Specific Response  .............................................................................................. 44 
 IV.3 Hen Egg Lysozyme Amyloid Aggregates Kinetic Phase Diagram and  
 Critical Oligomer Concentration (COC)  ................................. ……………………………………46 
 IV.3.1 Mapping the Hen Egg White Lysozyme Amyloid Phase Diagram ............46 
 IV.3.2 Amyloid Oligomer and Curvilinear Fibrils Share a Common 
 Transition Boundary ...................................................................................49 
 IV.3.3 Amyloid Oligomers and Their Curvilinear Fibrils Are 
 Thermodynamically Metastable  .................................................................50 
 IV.3.4 Precipitation Boundary: Structural Analysis via Infrared 
 Spectroscopy  ..............................................................................................51 
 IV.3.5 Model of Colloidal Charge Repulsion Reproduces Critical 
 Oligomer Concentration Boundary  ............................................................53 
 IV.4 Hen Egg Lysozyme Rigid Fibrils Nucleation Mechanisms Above and  
 Below the Critical Oligomer Concentration  .............................................................54 
 IV.4.1 Amyloid Nucleation and Growth Kinetics Reflect Basic  
 Aspects of Amyloid Phase Diagram  ..........................................................55 
 IV.4.2 Amyloid Phase Diagram Permits Unbiased Test of On- 
 Pathway Nucleated Conformational Conversion vs. Competitive  
 Nucleated Polymerization  ..........................................................................59 
  
V. Conclusions/Discussion  ...........................................................................................................66 
 
References  .....................................................................…………………………………………71 
 
Appendices  ....................................................................................................................................89 
Appendix A: Oligomer and Precipitate Solubility Boundary Theoretical Model  ........................89 
 A.1 Model of Colloidal Charge Repulsion Reproduces Critical Oligomer  
 Concentration Boundary  ............................................................................89 
 A.2 Loss of Colloidal Stability Predicts Onset of Oligomer Precipitation  .......................92 
Appendix B: Methods Theoretical Background  ...........................................................................95 
 B.1 Static and Dynamic Light Scattering Theoretical Background  .....................……….95 
 B.2 Thioflavin T Fluorescence Theoretical Background  ................................................102 
 B.3 Protein Fourier Transform Infrared Spectroscopy Theoretical 
 Background  ..............................................................................................104 
 B.4 Atomic Force Microscopy Theoretical Background  ................................................107 
 B.5 Circular Dichroism Spectroscopy Theoretical Background .....................................110 
 B.6 Gel Electrophoresis Theoretical Background  ..........................................................111 
Appendix C. Copyright Permissions ...........................................................................................112 
 
Appendix References  ..................................................................................................................120 
iii 
 
 
 
 
 
 
LIST OF TABLES 
 
Table 1  Amyloid Diseases and Its Associated Polypeptides or Proteins  ...................................2 
 
Table 2  Amide I Band Assignment to Protein Secondary Structure Motifs 
 Empirical vs. Theoretical Values  ................................................................................23 
 
Table 3  Comparison of Native vs. Amyloid Fibrils Core β-sheets  ..........................................24 
 
Table 4  Summary of Rigid and Oligomers/Curvilinear Fibrils Morphologies 
 Determined by Atomic Forces Microscopy  ................................................................36 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
iv 
 
 
 
 
 
 
 
LIST OF FIGURES 
 
Figure 1  Structural, Kinetic, Morphological and Fluorescence Characterization 
 of Amyloid Fibrils .........................................................................................................5 
 
Figure 2  Rigid Fibrils Lag Period Determination  .....................................................................18 
 
Figure 3  Hen Egg White Lysozyme Native Structure  ...............................................................28 
 
Figure 4  Hen Egg White Lysozyme Secondary and Tertiary Structure at pH 2  
 and pH 7  ......................................................................................................................29 
 
Figure 5  Structural Homology of Hen Egg White and Human Lysozyme  ...............................31 
 
Figure 6  Static Light Scattering, Dynamic Light Scattering and Atomic Forces 
 Microscopy Signatures of Rigid Fibrils Growth  .........................................................33 
 
Figure 7  Static Light Scattering, Dynamic Light Scattering and Atomic Forces 
 Microscopy Signatures of Oligomers/Curvilinear Fibril Growth  ...............................35 
 
Figure 8  Debye Ratio and Interaction Parameter for Hen Egg White Lysozyme 
 Monomers at pH 2, 20ᵒC  .............................................................................................37 
 
Figure 9  Infrared Spectra of Late Stage Fibrils in Either Pathway Show  
 Distinct β-sheet Peaks  .................................................................................................40 
 
Figure 10  Amide I Spectra and Their Time Evolution for Lysozyme Undergoing 
 Oligomeric Fibril Growth  ...........................................................................................41 
 
Figure 11  Thioflavin T Response to Hen Egg White Lysozyme Aggregation Kinetics  .............43 
 
Figure 12  Hydrolysis Effects on Pathways and Thioflavin T Response During 
 Kinetics Measurements  ...............................................................................................45 
 
Figure 13  Morphology and Kinetics of Rigid Fibrils, Oligomers, Curvilinear Fibrils 
 and Precipitates Formed by Hen Egg White Lysozyme  .............................................47 
 
Figure 14  Kinetics Phase Diagram for Rigid Fibrils, Oligomer and Curvilinear 
 Fibrils and Precipitate Formation of Hen Egg White Lysozyme  ................................49 
v 
 
 
Figure 15  Oligomer vs. Curvilinear Fibrils Formation, Metastability of Oligomer 
 Phase Against Rigid Fibrils Growth, and Amyloid Structure of Precipitates  .............52 
 
Figure 16  Kinetics Phase Diagram for Rigid Fibrils, Oligomer and Curvilinear 
 Fibrils and Precipitate Experiment vs. Theory  ...........................................................54 
 
Figure 17  Supersaturation as a Driving Force for Pathway Switch  ............................................56 
 
Figure 18  Growth Kinetics and Aggregate Morphologies Below and Above Critical 
 Oligomer Concentration ..............................................................................................58 
 
Figure 19 Schematics of Nucleated Conformational Conversion (NCC) vs. Nucleated 
 Polymerization (NP) of Rigid Fibrils  ..........................................................................61 
 
Figure 20  Schematic of Anticipated Changes in Rigid Fibrils Lag Period Upon 
 Crossing of Critical Oligomer Concentration for Nucleated Polymerization 
 (NP), Nucleated Conformational Conversion (NCC) and Nucleated 
 Polymerization (NP) with aO Buffering  .....................................................................62 
 
Figure 21  Lag Periods for Rigid Fibrils Nucleation Below and Above the Critical 
 Oligomer Concentration ..............................................................................................63 
 
Figure 22  Lag Periods for Rigid Fibrils Nucleation upon ―Seeding‖ with Oligomers 
 and Curvilinear Fibrils Below the Critical Oligomer Concentration  ..........................65 
 
 
 
 
 
 
 
 
 
vi 
 
 
 
ABSTRACT 
 
 Deposition of protein fibers with a characteristic cross-β sheet structure is the molecular 
marker associated with human disorders ranging from Alzheimer's disease to type II diabetes and 
spongiform encephalopathy. Given the large number of non-disease related proteins and peptides 
that have been shown to form amyloid fibrils in vitro, it has been suggested that amyloid fibril 
formation represents a generic protein phase transition. In the last two decades it has become 
clear that the same protein/peptide can assemble into distinct morphologically and structurally 
amyloid aggregates depending on the solution conditions. Moreover, recent studies have shown 
that the early stage, oligomeric amyloid assemblies are the main culprit in vivo. We have 
investigated the amyloid assemblies formed under denaturing conditions for Hen Egg White 
Lysozyme (HewL) whose human homologue is directly implicated in hereditary non-neuropathic 
systemic amyloidosis. Our early investigations showed that HewL can aggregate via at least two 
distinct assembly pathways depending on solution ionic strength at fixed pH, temperature, and 
protein concentration. By combining Dynamic Light Scattering (DLS), Static Light Scattering 
(SLS) and Atomic Force Microscopy (AFM) we showed that at low ionic strength, the pathway 
is characterized by the nucleation and growth of long (several micron), rigid fibrils (RF) via 
monomers assembly. A second, high ionic strength pathway is characterized by the rapid 
assembly of monomers into globular oligomers that further polymerize into curvilinear fibrils 
(aO/CF). At NaCl concentrations above 400 mM, aggregation resulted in precipitate formation. 
vii 
 
Next, we used Foureir Transform Infrared spectroscopy (FTIR) and an amyloid-specific dye, 
Thioflavin T (ThT), to show that both RF and (a)O/CF are amyloidogenic species, but they have 
detectable structural differences. Moreover, we have determined that each assembly pathway has 
unique SLS, DLS, FTIR and ThT response signatures that help determine the assembly type 
prior to AFM imaging of aggregates.  
Taking advantage of the morphological, structural and kinetic signatures for the two distinct 
HewL amyloid aggregates I mapped out their amyloid aggregates phase diagram spanning over 
two orders of magnitude in protein concentration and from 50 to 800 mM NaCl in ionic strength. 
This is the most complete phase diagram for amyloid aggregates of a given protein up to date. 
The phase diagram has three distinct regions delineated by sharp boundaries. The RF- aO/CF 
was called Critical Oligomer Concentration, and we commonly refer to ―above the COC‖ as the 
region were aO/CF are kinetically favored.. In the region of low salt/high protein concentrations, 
RF were the only amyloid species to nucleate and grow. As both salt and protein concentrations 
increase, aO/CF become the kinetically favored species, and RF nucleate and grow after several 
days of incubation. At high protein and high salt concentrations, aO/CF form very fast and 
eventually lose solubility forming a precipitate (Ppt). Cross-seeding experiments showed that RF 
is the thermodynamically stable aggregate phase, while the O/CF are the metastable species. 
Finally, we used the phase diagram to design experiments that would allow us to reveal the RF 
nucleation mechanism in presence of aO/CF. RF nucleation above the COC can undergo either 
via internal restructuring of aO/CF (NCC) or through a random coalescence of monomers into a 
nucleus (NP). The experimental results obtained so far strongly indicate that RF nucleate via NP 
mechanism both below and above the COC.   
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I. INTRODUCTION 
 
I.1 Amyloidosis as Health Care Challenge 
 Amyloidosis is the general term for a series of diseases characterized by extracellular 
depositions of insoluble protein fibrils in tissues and organs 
1–3
 (table 1). The most familiar 
amyloid diseases are Alzheimer‘s disease (AD), Parkinson disease (PD), Huntington disease 
(PD), systemic immunoglobulin light chain amyloidosis (AL) and the familial transthyretin 
associated amyloidosis (TTR). Up to now, nearly all amyloid diseases are incurable and present a 
major healthcare and economic problem. In 2015 alone, 18.1 billion unpaid hours at an estimated 
cost of 221 billion dollars have been spent by families and communities in the United States on 
care giving for Alzheimer and other dementia patients.
4
 Approximately 10 - 20% of people over 
65 years has been estimated to have a mild cognitive impairment due to Alzheimer,
5
 while 
cardiac TTR amyloidosis occurs in 8 -16% in people over 80 years old.
6
  
The term ―amyloid‖ is attributed to Virchow7 and it is directly translated as ―starch‖ from Latin. 
Virchow noticed that the homogeneous portions of autopsy tissue stained with iodine and 
sulfuric acid presented tinctorial characteristics (i.e., staining properties) similar to cellulose, 
hence he considered amyloid accumulations to have a carbohydrate molecular basis. Amyloid 
depositions in organs were described as homogeneous, greasy, pale yellow colloidal particles 
and, occasionally, as white, fibrillar outpourings.
2,3,7
 Biochemical studies by Friedrich and
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Table 1. Amyloid Diseases and Its Associated Polypeptides or Proteins. 
Disease Precursor protein Amyloid protein 
Alzheimer‘s disease Amyloid precursor protein Aβ peptides 
Atrial amyloidosis Atrial natriuretic factor (ANF) Amyloid ANF 
Spongiform encephalopathies Prion protein (PrPc) PrPsc 
Primary systemic amyloidosis Immunoglobulin light and 
heavy chains 
AL and AH 
Senile systemic amyloidosis Wild-type transthyretin ATTR 
Haemodialysis-related 
amyloidosis 
β2-microglobulin Aβ2M 
Hereditary nonneuropathic 
systemic amyloidosis 
Lysozyme ALys 
Type II diabetes Pro-IAPP IAPP or ―amylin‖ 
Injection-localized amyloidosis Insulin AIns 
Secondary systemic 
amyloidosis 
(Apo) serum amyloid A Serum amyloid A 
Hereditary cerebral amyloid 
angiopathy 
Cystatin C ACys 
Finnish hereditary systemic 
amyloidosis 
Gelsolin AGe 
Familial amyloid 
polyneuropathy I 
Transthyretin variants ATTR 
Familial amyloid 
polyneuropathy II 
Apolipoprotein A1 AApoA1 
Ageing pituitary, prolactinomas Prolactin APro 
Familial amyloidosis Fibrinogen αA-chain AFib 
Adapted with permission from Rambaran and Serpell, Prion, 2008, 2:3, 112-117, Table 12 
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Kekule in 1859 showed that amyloid fibrils were built from polypeptides; however the term 
―amyloid‖ was not changed to reflect that,8 and this term is exclusively used in the modern 
literature. 
 
I.2 Structural Hallmarks of “Classical” Amyloid Fibrils 
 In the beginning of twentieth century, Divry and Florkin showed that Congo Red, a 
cytoplasm and erythrocyte stain, tightly binds to amyloid fibrils in tissue samples and exhibits an 
intense birefringence with respect to the long axis of these deposits, appearing apple green under 
polarized light
9–11
. The birefringence indicated that these proteinaceous depositions were not 
amorphous, but rather had a well-defined underlining structure. Further, Thiovlavin T has been 
identified to bind tightly to amyloid fibrils and it has been extensively used for studying growth 
kinetics since this discovery in 1959
12–15
.  
Electron microscopy done on tissue specimens showed ―the fine curved nature of the fibrils‖16 
that were either disorderly distributed or in bundles, depending on the organ/animal. Regardless 
of animal or organ origin, the fibrils had very similar widths of 0.5- 14 nm and length of 1-16 
µm, and their morphology was clearly distinct from any non-pathological protein fibril known at 
that time
11,16
. In 1968, the hallmark cross-β sheet structure of amyloid fibrils was resolved from 
X-Ray diffraction of both human and animal amyloid tissue extracts. In their article, Eanes and 
Glenner revealed the well-known rings at 4.75 Å overlaying a diffuse halo at 4.3 Å, and a 9.8 Å 
ring present in non-oriented fibrils vs. the ―cross-β‖ X-Ray pattern from oriented fibrils17.  
4 
 
In 1971, advancement in biochemical methods led to the identification of homogeneous 
immunoglobulin light chains as first plasma proteins able to undergo amyloid fibril formation
18
 
This was followed by the first in vitro growth of amyloid fibrils from κ and λ chains of Bence 
Jones proteins at acidic pH and physiological temperatures, mimicking renal tubes conditions
3,19
. 
The same year, Benditt and Eriksen isolated a different protein that was also involved in amyloid 
fibril formation and called it protein A
20
. In subsequent years, several other proteins have been 
reported to form amyloid fibrils in vitro, and substantial work has focused on isolation and 
biochemical identification of these proteins in human amyloid fibrils
21–27
.  
In 1998-99, in a series of four articles, Kelly, Dobson and Chiti established that amyloid fibril 
formation is an inherent property of polypeptide chains. They also showed that human proteins 
under specific, denaturing conditions undergo conformational changes of their tertiary and 
secondary structure that promoted amyloid fibrils formation
28–31
. This hypothesis was further 
supported by work from Aso et al. who generated amyloid fibrils under denaturing conditions 
from 25 non-disease related proteins
32
. 
Having established that amyloid fibril formation is an intrinsic property of the polypeptide 
backbone, scientists set out to find generic physical and biochemical parameters that would allow 
one to better understand amyloidogenesis. The starting point in this search was the amyloid 
cross-β sheet, since it is the common structural feature of all amyloid fibrils regardless of the 
protein of origin
33,34
. Using nuclear magnetic resonance (NMR) spectroscopy, by 1998 it was 
shown that Aβ fibrils have a parallel, in register cross-β sheet35. In 2000, based on powder X-ray 
diffraction of an amyloid forming yeast peptide, David Eisenberg and his colleagues proposed a 
model for amyloid fibrils as a dry (or dehydrated) in register, parallel-stranded, densely packed 
5 
 
β-sheet structure . The model explained the stability of the cross-β sheet core as being mainly 
entropically driven due to the large gain in entropy from water excluded from the rigid fibril 
core, with minor energy contributions from the hydrogen bonding of side chains among  
(a) 
 
 
(b) 
 
 
(c) 
 
(d) 
 
(e) 
 
(f) 
 
 
Figure 1. Structural, Kinetic, Morphological and Fluorescence Characterization of 
Amyloid Fibrils. (a) characteristic kinetics curve for amyloid fibril nucleated polymerization 
indicating the nucleation lag period, growth (polymerization) period and the equilibrium 
plateau
43
 (b) ThT fluorescence response upon binding to amyloid fibrils. Notice the orders of 
magnitude increase in fluorescence emission in presence of amyloid fibrils
43
 (c) Morphologies of 
human lysozyme amyloid fibrils formed at pH5, 10% TFE, 68ᵒC and vigorous stirring (d) 
characteristic X-Ray diffraction pattern of amyloid fibrils. Notice the anisotropic reflections at 
4.7 Å and 10 Å44 (e) cartoon schematics of amyloid fibrils β sheets and amyloid cross-β core. 
Notice the origin of the reflection at 4.7 Å and 10 Å observed in the diffraction pattern45 (f) 
view of the dry steric zipper. Notice the protruding residues and their steric accommodation 
between the sheets backbones
2
. 
Figure 1: Structural, Kinetic, Morphological and Fluorescence Characterization of Amyloid 
Fibrils (Continued on Next Page) 
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Fig. I.B.1a,b: adapted with permission from Arosio et al. Phys. Chem. Chem. Phys., 2015, 17, 
7606—7618, Fig. 3a and 6b respectively 
Fig. I.B.1d,f: adapted with permission from Rambaran and Serpell, Prion, 2008, 2:3, 112-117, 
Figure 22 
Fig. I.B.1e: adapted with permission from Smith et al. Life 2014, 4, 887-902, Fig. 1 
 
themselves in the absence of water
36
. A few years later, Eisenberg and his team put forward a 
complete model of the cross-β spine of amyloid-like fibrils as a tightly self-complementing steric 
zipper formed by the side chains bulging from two adjacent fibril sheets that helps to clamp the 
sheets together
37,38
 (fig. 1). Subsequent investigations of short peptides derived from various 
amyloid proteins lead to identification of eight different classes of zippers based on sheets 
positioning and the compatibility
39
 of the side chains. Using amyloid fibrils and a combination of 
experimental techniques spanning over five orders of magnitude physical length, Dobson and his 
colleagues showed that the two dimensional β-sheets associate further into tertiary 
protofilaments, quaternary filaments and then fibrils
40
. The extensive work on amyloid fibrils 
structure of Blacke, Kirshner, Eisenberg, Dobson and other groups showed that the cross-β sheet 
arrangement is a delicate balance between entropy (hydrophobic interactions, 
translational/rotational entropy of water molecules or peptide backbone, side chains steric 
contributions) and energy (hard core repulsion, Coulomb interactions like charge-charge, dipole-
charge or dipole-dipole with hydrogen bonding being a special and major contributor)
33–42
. 
 
I.3 Amyloid Aggregation Pathways 
 Parallel to intensive studies done on generic long rigid fibrils‘ amyloidogenesis, evidence 
was accumulated that proteins can concomitantly or sequentially explore various non-fibrillar 
amyloid aggregate states under identical solution condition
46–48
. Well-defined early stage 
7 
 
aggregate populations have been identified both in vivo and in vitro
48–51
 and have been called 
oligomers due to their small size. It has been suggested that oligomers can further polymerize 
into worm-like/curvilinear fibrils
52–57
 and nucleate the late stage rigid fibrils
55–59
. Initial in vivo 
detections of early stage oligomeric species suggested that they are the most toxic amyloid 
populations
46,47
, and subsequently in vivo evidence that supported early in vitro findings was 
gathered 
63–66
. Up to date, there is still conflicting evidence regarding the toxicity of the early 
stage amyloid aggregates
66–68
. 
A complete picture of amyloid fibrils formation has to incorporate early stages oligomeric 
populations as well as end stage amyloid aggregates and be consistent with the structural data of 
the cross-β sheet atomistic description. It has become clear that amyloid aggregation is a 
complex process and models describing this process have to account for both the generic 
character of amyloid aggregation as well as the individual physical parameters of peptides and 
protein 
69,70
. Special attention has been dedicated to the fate of early stage oligomers and their 
subsequent curvilinear fibrils since, for the overwhelming majority of amyloid proteins, they are 
not the end stage amyloid product in vivo or in vitro 
48,64–66,68
. This latter conundrum highlights 
the necessity of following the aggregation process in situ and identifying the relevant assembly 
mechanisms at work at different time points. 
 
I.4 Amyloid Aggregation Mechanisms 
 One of the most common approaches to study amyloid aggregation is to monitor its 
kinetics in vitro for a wide spectrum of amyloid proteins/peptides. The kinetic curves have been 
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extensively used to infer molecular details of the aggregation process and multiple molecular 
mechanisms have been put forward based on the analysis of aggregation kinetics alone
69,71–77,71
 .  
The study of protein polymerization kinetics in order to obtain details on molecular mechanisms 
of supramolecular self-assembly goes back to work by Oosawa for actin polymerization
79–81
 . His 
model paved the way for nucleated polymerization aggregation mechanism for proteins and it 
has remained the most dominant aggregation model until now. In his works he introduced the 
notion of critical concentration as the concentration threshold for aggregate nucleation. Also, 
Oosawa group described the cooperative nature of actin fibrils polymerization and how the 
nucleation lag period can be removed by seeding the sample with pre-formed fibrils. In order to 
get a meaningful physical model of actin polymerization process that would fit the empirical 
data, Oosawa and his colleagues had to make the distinctions between the substrate monomers 
(G-actin) and the monomer state that is incorporated into polymers/fibrils (F-actin) and assign 
each actin type different energy and entropy contributions to the total energy of the system
76–78
. 
Discrepancies between actin and flagilin end stage polymerization experiments results and his 
model‘s predictions lead him to introduce two additional concepts fibrils depolymerization and 
fragmentation and a description of the polymer size redistribution at the end of polymerization 
when association and dissociation occur at comparable rates
82. After Oosawa‘s description of 
actin polymerization, the model was modified to introduce a separate step describing the 
nucleation event. During their work on hemoglobin, Eatons‘ group described the 
thermodynamically unfavorable nucleus
83,84
 and assigned it a low rate of formation which lead to 
a lag period associated with the nucleation event in the kinetics. As a result of combining 
Oosawa and his colleagues work and further developments from Eaton‘s group, the characteristic 
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sigmoidal shape of nucleated polymerization (NP) with three regions (lag period, elongation, 
plateau/equilibrium) became the protein aggregation kinetics signature
85
.  
It is essential to realize that the nucleated polymerization aggregation model was developed in 
the context of fully reversible aggregation that did not require protein denaturation or chemical 
or specific bonds formation during polymerization.  
Subsequent modifications of the nucleated polymerization model have been introduced based on 
observations of different protein aggregation kinetic curves under denaturing conditions (i.e., 
amyloid fibril aggregation). Scientists have tried to redefine the nucleus size, the forward and 
backward polymerization rates, introduce different rates for each polymerization step, different 
rates for nucleation before and after the polymerization began, or defined ―catalytic surfaces‖ on 
protein aggregates surfaces
85–92
. Additional modifications to the model were made to generalize 
the nucleation event as an arbitrary step with the lowest rate and to allow (de)polymerization via 
small oligomers not monomeric addition only
93–95,72–75
.  
A crucial step for the study of protein aggregation mechanisms was the discovery of prion 
proteins and their inherent infectivity by Pruisner
27,96
. The model for prion aggregation was 
based on Griffith‘s mathematical model97 of Templated Assembly, where the ―reactive‖ 
monomeric species P would be an isomer of the inactive/native monomer C. The transformation 
of C into P is thermodynamically unfavorable (they have very dissimilar energies), while the 
formation of a P dimer from two P monomers is thermodynamically favorable. After the 
formation of the P dimer, the C monomeric isomer is further transformed into the P isomer 
through the interaction with the P dimer or larger subsequent aggregates. In the end a mixing 
between the nucleated polymerization and Griffiths‘ template assembly, Nucleation-Dependent 
10 
 
Polymerization (NDP), was the most accepted model for prion aggregation and infectivity
98
. 
According to the model, there is equilibrium between the C and P isomers of the same protein. 
The nucleus forms from the P form and has an assigned nucleation rate. Once the nucleus forms, 
the equilibrium between the C and P tends to replenish the P population and hence serves as a 
driving force for further conversion. The further conversion of C into P is catalyzed by the 
present P oligomers which are now in solution; hence the growth is rapid
98–100
. 
In 2000, Lindquist and her lab proposed another model that combined yet again the Griffith and 
Lansbury
48,101,102
 models and called it Nucleated Conformational Conversion (NCC). In this 
model, C, the ―normal‖ monomers form quickly the kinetically favored C oligomers (nuclei) that 
undergo a slow internal conversion into the thermodynamically more stable P rigid fibril nuclei, 
hence the rigid fibrils nucleus formation is a two-step process. The P fibril can further 
polymerize from C oligomers or a C monomer. The C oligomers or monomers undergo a rapid 
internal restructuring upon interaction with the P polymer and the entire growth is fast
58
. So, the 
―infectious‖ entity is the P oligomer (rigid fibril nucleus) and the polymerization occurs via the 
converted C oligomers and C monomers. While NCC has been shown to fit, to various degree of 
accuracy, the kinetic curves for aggregation of several proteins
58,59,61,62,103
, it still leaves open the 
question of what are the molecular mechanism of the internal structural conversion of P 
oligomers and how common the NCC protein aggregation scenario is. 
 
I.5 Amyloid Species Phase Diagram(s) and Their Importance in the Field  
 Amyloid aggregation has been described in more detail in the context of statistical 
thermodynamics as a region in protein phase diagrams
104–108
 or as a self-assembly process
109,110
. 
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This statistical mechanics framework allows to determine the role of short vs. long range 
interactions, as well as the strength vs. specificity of these interactions
52,104,106,107,111–116
 in 
resolving the molecular mechanism(s) of amyloid aggregation under given solution conditions. 
Based on the nature and extent of the physical interactions between the protein monomers in 
solution, it is possible to build equilibrium phase diagrams that give a holistic picture of the type 
and relationships of different amyloid aggregate phases. One of the earliest attempts to build 
experimentally aggregate phase diagrams was presented by Radford‘s group54. They used protein 
concentration vs. pH and protein concentration vs. salt concentration to map out the type of 
aggregates formed at different ionic strengths and β2-microglobulin concentrations in solution. 
At low ionic strengths, the typical long straight amyloid fibrils would form via NP, while at high 
ionic strength solution conditions, non-nucleation dependent (how do they know that if they only 
monitored results after 3 weeks?) worm like fibrils and oligomers would form. The Radford team 
monitored amyloid aggregation for three weeks, so it is unclear if the species detected are the 
end product of aggregation under the given solution conditions or they are the kinetically favored 
amyloid state. Also, the protein, salt and pH ranges are very limited and amorphous phases were 
excluded from consideration.  
Several years later, Goto and his team identified structureless aggregate phases for β2-
microglobulin they related to a glass phase, and also defined a transition curve between the 
amorphous and the fibrillar (crystal-like) aggregate states
107
. They showed that aggregation is 
supersaturation driven and that the amorphous state is metastable with respect to the fibrillar 
state. Their work complemented the of the Radford team by identifying the amorphous phase 
beyond the worm-like and long fibrils. However, their transition curve for the amorphous state 
delimits amorphous aggregates as a generic state of proteins and not an amyloid state. In 
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addition, they do not show solubility curves of different amyloid species; hence the phase 
diagram they build is a protein phase diagram, not an amyloid aggregates phase diagram. The 
mere identification of amyloid aggregates as a phase did not show the equilibrium or kinetic 
relationship between the worm like fibrils and the long straight fibrils, so this core question 
remained unanswered. 
 
I.6 Motivation and Goals for My Research 
 During my undergraduate work in Dr. Muschol‘s laboratory I was fortunate to work with 
the graduate student that identified and characterized the morphologies of HewL amyloid 
aggregates under denaturing conditions
52
. We also showed that the net two-body interaction of 
protein monomers in solution was a key physical parameter for HewL aggregation. Working on 
this project under her and Dr. Muschol‘s guidance served as my main motivation to continue 
working on revealing further physical parameters that affect the molecular mechanisms of 
protein self-assembly processes.  
I have continued my work towards my set goal by working with our team on the next step 
throughout my first year of graduate studies on characterizing the kinetics and structure of HewL 
amyloid aggregates we previously identified
117
.  
The works of Radford and Goto presented in Section I.E proved that amyloid aggregates phase 
diagrams are powerful tools for understanding the kinetics and themodynamics of 
amyloidogenesis. The experimental evidence (including our own) that two-body electrostatic 
interactions and initial concentration of protein monomers in solution play a crucial role in 
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dictating the aggregation‘s outcome51,107,111-113 suggested that these are also two key parameters 
controlling the aggregate phase space. 
 Uniquely positioned to work with an amyloidogenic protein system where all three aggregates 
states (long straight, curvilinear and amorphous), I set out to map an entire phase diagram within 
the protein concentration vs. ionic strength phase space and to determine the relationship 
between the amyloid aggregate phases. Moreover, the phase diagram would have provided us 
with both a qualitative and quantitative understanding how various aggregation mechanisms 
translate into the corresponding assembly kinetic curve signatures. They would have also 
allowed us to identify the driving forces and the molecular mechanism underlying amyloid 
aggregation in our system.  
Once I mapped out the phase diagram for HewL amyloid aggregates, we set out to use it in 
answering one of the main conundrums in the amyloid aggregation field, namely the nucleation 
mechanism of rigid fibrils (the end stage aggregates) in presence of early oligomeric stage 
amyloid aggregates.  
A holistic picture of both kinetics and thermodynamics of amyloid aggregation in vitro would 
greatly contribute to understanding the clinical phenomenology of amyloid diseases and 
contribute to designing molecular mechanisms to cure, prevent or delay amyloid diseases.  
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II. MATERIALS AND METHODS 
 
II.1 Materials and Sample Preparation Protocols 
 In section 1 I describe in details the protocols for sample preparation and materials used, 
as well as curve fitting for kinetics data and extraction of lag periods for RF nucleation.  
 
II.1.1 Fresh Hen Egg White Lysozyme Sample Preparation 
 Two times recrystallized, dialyzed and lyophilized HewL purchased from Worthington 
Biochemical Corporation (cat#.: P00698) in buffer without additional NaCl at desired pH value 
at double the desired final concentrations (25 mM KH2PO4 / H3PO4 for pH2 (Sigma Aldrich 
ACS reagent ≥ 99% CAS 7778-77-0/ Fisher ACs grade CAS 7664-38-2), 100 mM C6H8O7 / 
C6H5Na3O7 for pH5 (Fisher ACS CAS 5949-29-1/6132-04-3), and 20 mM HEPES (Fisher CAS 
7365-45-9) or 100 mM NaH2PO4 / Na2HPO4 for pH7, ACS reagent ≥ 99%, ). The buffers are 
pre-filtered through a 220 nm PES Corning bottle-top filter. HewL samples were incubated at 42 
ᵒ
C in a water bath for 2 minutes in order to dissolve any mesoscopic aggregates formed during 
the lyophilization process. After the water bath, the samples were filtered through a 200 nm 
Fischerbrand nylon syringe filter (cat# 09-719C) and a 50 nm Thermo Scientific cellulose acetate 
syringe filter (cat# 03-376-230). The protein concentration was measured using absorption at 
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280
1
 nm with a ε280 = 2.64 ml*(mg*cm)
-1
 and adjusted if needed through dilutions. The HewL 
samples were then gently mixed 1:1 with a buffer solution at double the desired final NaCl 
(Fisher CAS 7647-14-5) concentrations.  
 
II.1.2 Thioflavin T Stock Preparation 
 ThT stock was prepared by dissolving ThT powder (Anaspec Inc. cat.# 88306) into DI 
water from Millipore reverse osmosis system and the solution was filtered through the above 
mentioned 220 nm and 50 nm pore size syringe filters. The actual concentration was measured at 
412
120
 nm using ε = 32000 M-1 cm-1 using UV Spectrometer (DeNovix DS-11 FX+) ThT stock 
solution was stored at 4ᵒC for less than 30 days.  
 
II.1.3 Rigid Fibrils and Curvilinear Fibrils Aggregates for Isolation 
 After the preparation of the HewL desired stock solution, the final sample were obtained 
by diluting the stock using the same salt buffer filtered through the 220 nm and 50 nm syringe 
filters (see above stock preparation protocol). If multiple protein solutions concentrations were 
needed, usually a series dilution was used. The sample were put in test 15 ml centrifuge tubes 
(Thermo Scientific cat.# 339650) at 52 ᵒC in dry bath (Labnet, AccuBlock Digital Dry bath). If 
occasional monitoring with DLS/SLS or ThT monitoring of aggregation was needed, the sample 
was incubated in a glass or quartz cuvette with stopper (see below DLS/SLS measurements 
protocol). 
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II.1.4 Rigid Fibrils Isolation Protocol 
 RFs prepared under at the same solution as the solution they would be used as either seed 
or initial RFs sample were isolated through a series of centrifugations. The initial sample was 
placed in a 2 ml centrifuge tube and spun down for 20-24 hours at 17700xg in centrifuge (Fisher 
Scientific AccuSpin 1R) at 4 ᵒC. The formed pellet would be re-dissolved in buffer and spun for 
another 20-24 hours. This cycle would be repeated until the concentration of the supernatant 
after the centrifugation reached less than 1% of the pellet concentration. The supernatant was 
also checked with Dynamic Light Scattering (see below) to detect if there were any RFs 
contaminants left in the supernatant. After the last spin, the sample was spun down at 5000xg for 
30 minutes to precipitate any large or insoluble RFs clumps induced by centrifugation cycles. 
The RFs morphologies and pad presence of any residual clumps were checked with 
Transmission Electron Microscopy (TEM, see methods below). In order to check that the 
centrifugation protocol was efficient at removing monomers, after the last spin, I dialyzed the 
RFs at room temperature for 3 days and 6 changes of buffer and compared amyloid motif 
identifying dye Thioflavin T fluorescence (see methods below) of the same nominal RFs 
concentrations from dialyzed and non-dialyzed RFs samples. The ThT fluorescence at 25ᵒC from 
both dialyzed and non-dialyzed RFs samples were the same within experimental error, indicating 
that there were no significant differences between the samples‘ RFs concentrations. 
Isolating aggregates using cut-off filter was similar. 400 mL of aggregated sample was put in a 
50 kDa cut-off filter (Amicon Ultra, cat.# UFC505024 ) and spun down at 15000xg for 15-30 
minutes. After the first spin, 350 mL of the same (or exchange buffer, if fibrils were to be used as 
seeds at a different buffer salt concentration) was added and the sample was spun down at the 
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same centrifuge settings. The last step was repeated 5 times. At the end, fibrils were recuperated 
by inverting the filter in a new centrifuge tube and spinning it at 3000xg for 5 minutes and 
dissolved in the buffer intended for further use.  
 
II.1.5 Curvilinear Fibril Decay Experiments 
 We generated curvilinear fibril seeds and isolated them from the residual lysozyme 
monomers via filtration using 100 kDa centrifuge cutoff filters. The thermodynamic stability of 
these seeds was tested by adding them to a series of solutions at fixed protein concentration (1.4 
mM and 0.692 mM). However, a range of salt concentrations (0−300 mM NaCl) was chosen to 
cross the boundary for rigid filament-to-oligomer formation using 25 mM increments in NaCl 
concentration. For low protein concentration, NaCl concentration was fixed at 350 mM, and 
HewL concentrations varied from 0.5 mM down to 0.035 mM. Total protein concentration was 
taken as the sum of both monomer and seed concentration. By using this approach, the solution 
conditions crossed the transition boundary perpendicular to its local slope, and the experimental 
accuracy improved. 
 
II.1.6 Determination of Rigid Fibrils Nucleation Lag Periods 
 Protein solutions at concentrations ranging from 0.03 mg/ml (1.6 µM, below the COC) to 
5mg/ml (700 µM, above the COC) were incubated in the presence of either 450 or 500 mM 
NaCl. Protein concentrations were more closely spaced near and below the COC for a given salt 
concentration, and more widely spaced above the COC. The kinetics of three wells of identical 
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solution composition were typically averaged, while the statistical variance was reported for 
curve fitting and RF nucleation estimation times from each individual curve. For quantification 
of RF lag periods below the COC, we defined the lag phase as the point at which the amplitude 
of the ThT signal increases beyond a fixed threshold above the initial baseline. Using semi-
logarithmically scaled ThT intensities significantly improves the sensitivity to detect the onset of 
discernible RF growth from seeds nucleated up to that point. Above the COC, the initial growth 
phase was fitted with a saturating (double)exponential over the range corresponding to aO/CFs 
growth (including the plateau, until the second up rise in the kinetic curve). The fitted curve was 
subtracted from the total curve and the resulting difference curve was assigned to correspond to 
the parallel RF growth. The lag period of RF nucleation was estimated using the same method as 
for RF growth below the COC.  
(a) 
 
 
 
Figure 2: Rigid Fibrils Lag Period Determination (Continued on Next Page) 
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(b) 
 
 
Figure 2. Rigid Fibrils Lag Period Determination. (a) For determining the lag period for RF 
below the COC, the lag period is fitted with a line and then a fix ThT net increase above this 
baseline is taken as the lag period. (b) For determining the lag period of RF above the COC, the 
curve is first fitted with a saturating exponential, then the fitted curve is subtracted from the 
experimental curve. The difference curve is considered the curve corresponding to the RF growth 
under these conditions. The lag period is determined in the same way as for RF below the COC. 
 
 
II.2 Methods and Measurements Parameters 
 In section 2 I describe in details the protocols for sample measurement parameters and 
instruments used to obtain kinetic, structural and morphological information on aggregation 
behavior of hewL samples. A detailed description of theoretical principles of the methods I used 
in my PhD work are given in part B of the appendix. 
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II.2.1 Static and Dynamic Light Scattering Kinetics Measurements  
 Samples were incubated at 52 
ᵒ
C in a 10 mm Starna glass cuvette topped with a PTFE 
stopper in a SLS/DLS instrument from Zetasizer Nano S, Malvern Instruments Ltd.. The 
instrument is equipped with a 3 mW He-Ne laser with 633 nm wavelength and measuring back 
scattering at θ = 173ᵒ, and it has a built in Peltier temperature control unit with a nominal 
accuracy of ± 0.1 
ᵒ
C. Samples were measure at intervals ranging from 15 minutes to 30 minutes, 
and each data point was the average result of a 3 minute interval signal acquisition. Sample 
particle size distributions and their relative percent areas were obtained using the built in Contin 
deconvolution analytical package. Correlation functions were routinely checked to assure good 
quality data acquisition. Data was analyzed and plotted using Wavemetrics scientific graphing, 
data analysis, image processing and programming software Igor Pro 5. All initial protein 
solutions were prepared as indicated in Material section, unless otherwise specified. 
 
II.2.2 Thioflavin T Fluorescence Monitored Hen Egg White Lysozyme Amyloid Fibrils        
 Formation Kinetics 
 The bulk of the ThT fluorescence kinetics measurements were performed using a 
SpectraMax M5 grating-based fluorescence plate reader (Molecular Devices) equipped with a 
temperature-controlled sample chamber (Xdeg above ambient to 60° C). ThT fluorescence was 
excited at 440 nm, and emission collected at 488 nm in presence of a 455 nm long pass filter to 
suppress any scattered excitation light leaking into the emission channel. 200-325 μL aliquots 
were placed in a 96-well glass bottom plate (Cellvis P96-1.5H-N, Fisher cat.# NC0536760), and 
a ThT stock solution was added, which brought its final concentration to 10-30 μM. All 
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measurements were performed at 52 °C with the plate being shaken for 3-5 seconds every 10-20 
minutes. The plate was covered with either aluminum sealing tape (Corning, Fisher 
cat#07200684) or transparent silicone matt (Thermo Scientific cat.# 03252163). Kinetic curves 
were plotted using Igor Pro 5 (Wavemetrics), scientific graphing, data analysis, image processing 
and programming software. 
Alternatively, ThT fluorescence measurements were performed using a FluoroMax-4 
spectrofluorometer (Horiba Jobin Yvon, Edison, NJ) equipped with a built-in Peltier temperature 
control unit. ThT fluorescence was excited at 445 nm and emission spectra were measured 
between 465 nm and 565/600 nm. For each ThT fluorescence measurement, small sample 
aliquots were removed from the HewL growth solution and were mixed with the ThT stock 
solution. In order to minimize potential changes to the particle size distribution arising from 
dilution during ThT measurements, only 3.3 μl of the 212 μM ThT stock solution was added 
directly to 66.7 μl of the undiluted lysozyme aliquots, resulting in a final ThT concentration of 
10 μM. ThT/HewL mixtures were transferred into small volume quartz cuvettes and allowed to 
equilibrate for 5 min before recording ThT fluorescence emission. For each fluorescence 
measurement at least two separate ThT/HewL solutions were prepared and their fluorescence 
analyzed. Offline ThT fluorescence measurements were taken at regular intervals (typ. 2-6 
times/day) while light scattering was monitored in situ as described above. Correlated DLS/SLS 
and ThT measurements ceased when light scattering indicated the onset of sample gelation. All 
ThT measurements were taken at room temperature. Using DLS we confirmed that the addition 
of ThT, the minimal dilution of the samples for ThT measurements, or the lower temperature 
used during fluorescence measurements did not noticeably alter the size distribution of HewL 
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aggregates
35
. All initial protein and ThT stock solutions were prepared as indicated in Material 
section, unless otherwise specified. 
 
II.2.3 Fourier Transform Infrared Spectroscopy Measurement 
 Attenuated total reflectance Fourier-transform infrared spectroscopy (ATR-FTIR) was 
performed on a Bruker Optik Vertex 70 (Ettlingen, Germany) spectrometer with a mid-infrared 
source and pyroelectric DLATGS (deuterated L-alanine doped triglycene sulfate) detector. 
Measurements were taken by placing 25−30 μL of protein solution at 1.4 mM concentration on 
the thermostated silicon crystal of a BioATRcell II (Harrick Scientific Products, Inc., 
Pleasantville, NY) accessory. FTIR spectra were acquired between 1000 cm
-1
 and 4000 cm
-1
. All 
spectra were taken at 24 °C with an aperture setting of 8 mm and a scanner velocity of 10 kHz. 
Typically, 500-1000 scans at 4 cm
−1
 resolution were recorded, and three such runs were averaged 
prior to data analysis. Background spectra of the buffer solution without protein were recorded 
over 200 - 1000 scans at 2 - 4 cm
−1
 resolution and subtracted from the sample spectra. Only data 
that had a smooth, flat baseline in the 1750 - 2000 cm
-1
 region were chosen as suitable for further 
analysis. Typically, data analysis was performed on the average spectrum of three individual 
runs. The Amide I and Amide II bands (1500–1700 cm−1) were deconvoluted together. Peak 
positions in the Amide I band of the spectra were identified using the Fourier Self-deconvolution 
(FSD) (bandwidth 6 cm−1; enhancement factor 2.4) and second derivative (13 smoothing points) 
algorithms within the OPUS software analysis package (version 6.5, Bruker Optik). After a 
horizontal baseline correction, Gaussian curves were fitted from 1550 cm
−1
 to 1700 cm
−1
. The 
overlap of the Amide I and Amide II band was best estimated by fitting the entire Amide I band 
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together with the high-frequency portion of the Amide II band. Peak positions were fixed to the 
values identified by FSD and second derivative algorithms while the intensity and widths of the 
Gaussian curves were optimized using the Levenberg-Marquardt Algorithm. To avoid 
unreasonable broadening of Gaussian peaks observed for some spectra, peak widths were 
restricted to values near those obtained with native lysozyme. For comparing spectra from 
different fibril samples baseline corrected spectra were normalized to the integral over their 
Amide I bands. Difference spectra were obtained by subtracting the normalized reference 
spectrum of monomeric lysozyme from the spectra of the aggregated samples. These spectra 
were renormalized by dividing each by the values of their respective β- sheet peaks. 
For measurements of the temporal evolution of the FTIR difference spectra sample aliquots were 
removed at different times (4 h, 1 day, 4 days, 7 days, 11 days) and the initial monomer FTIR 
spectrum at 25 ◦C was used for subtraction121. All initial protein and ThT stock solutions were 
prepared as indicated in Material section, unless otherwise specified. 
Table 2. Amide I Band Assignment to Protein Secondary Structure Motifs Empirical vs. 
Theoretical Values. Notice the higher discrepancy between the empirical and theoretical values 
for α-helix. This discrepancy may arise from the experimental difficulty to have reliable data in 
that region of Amide I band due to the strong absorbance of water in the same exact region.  
 
Frequency (cm
-1
) Secondary Structure 
Associated 
Theoretical Value 
1620 - 1635  β-sheets 1627 (anti-parallel, weak)124,125  
1636 - 1643 β-sheets 1640 (parallel)125  
1644 - 1654  Random  - 
1654 - 1657 α-helix 1663
126 
1667 - 1685 β-turns 1665127 
1689 - 1698  β-sheets 1690(anti-parallel, 
strong)128,129  
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Band assignment of native of native HewL state was based on previous experimental
122,123
 and 
theoretical work which is summarized in table 2 above.  
The amyloid-β sheet band of FTIR spectrum has been assigned based on previous experimental 
data from various groups that I summarized in table 3 below. 
Table 3. Comparison of Native vs. Amyloid Fibrils Core β-sheets. Notice that amyloid fibrils 
core β-sheets emerge at lower frequencies than the native β-sheets for β2-microglobulin and 
human lysozyme, and appear de novo for Aβ42 and α-synuclein also at low wavenumbers. 
 
Protein/Peptide Aggregate Species Low Wavenumbers 
β-sheet Peak (cm-1) 
High Wavenumbers 
β-sheet Peak (cm-1) 
Aβ42  Monomer (pH 7.4) - - 
Oligomer (pH 7.4) 1626
130
 1695
130
 
Fibrils (pH 7.4) 1620
130
 - 
α-synuclein Monomers (pH 7.4) - - 
Oligomers (pH 7.4) 1625
131,132
 1695
131,132
 
Fibrils (pH 7.4) 1628
131,132
 - 
β2 microglobulin Monomers (pH 7.5) 1633
133
 - 
Oligomers (pH 2.1) 1618
133
 1684
133
 
Fibrils (pH 2.1) 1620
133
 - 
Human Lysozyme Monomers (pH 3) 1632
134
 - 
Oligomers (pH 3) 1630
134
 1688
134
 
Fibrils (pH7) 1626
135
 1693
135 
Fibrils (pH 2) 1622
135,136
 - 
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II.2.4 Atomic Forces Microscopy Imaging 
 AFM images were obtained in air with a MFP-3D atomic-force microscope (Asylum 
Research, Santa Barbara, CA) using NSC36/NoAl (Mikromasch, San Jose, CA) or PFP-FMR-50 
(Nanosensor, Neuchatel, Switzerland) silicon tips with nominal tip radii of 10 and 7 nm, 
respectively. The cantilever had a typical spring constant and resonance frequency of 2 nN/nm 
and 70 kHz, respectively. It was driven at 60−70 kHz in alternating current mode and at a scan 
rate of 0.5 Hz, and images were acquired at 512 × 512 pixel resolution. Raw image data were 
corrected for image bow and slope using Wavemetric‘s IgorPro 5 data analysis package. For 
aggregates, 75 μL of sample solutions was diluted 20- to 200-fold into the same salt/buffer 
combination used during growth, deposited onto freshly cleaved mica for 3−5 min, rinsed with 
deionized water, and dried with dry nitrogen. HewL monomers were not diluted and were 
deposited on freshly cleaved mica for 30 minutes before rinsing with deionized water and dried. 
Amplitude, phase, and height images were collected for the same sample area. False-color 
heights were subsequently superimposed over either amplitude or phase images off-line using 
Adobe Photoshop software. 
 
II.2.5 Circular Dischroism Spectroscopy Measurements 
 Circular dichroism (CD) measurements were performed on an AVIV Model 215 (Aviv 
Biomedical, Lakewood, NJ) or a Jasco J-815 (Jasco Inc., Easton, MD) CD spectrometer. Spectra 
of fresh HewL or amyloid aggregates were collected at 1 mg/mL (Aviv) or 0.2 mg/mL (Jasco) 
and 25°C at pH2 or pH7 using a high quality, 1 mm path length quartz cuvette. Wavelength 
scans were acquired between 190 and 260 nm in 1 nm increments. For measurements with AVIV 
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spectrometer, three scans with 10 seconds acquisition times each were averaged. When using 
Jasco 815 spectrometer, three scans at a rate of 20 nm/minute were averaged for each buffer and 
sample. In all cases, buffer spectra were subtracted from the corresponding sample spectra. 
Temperature scans were performed between 20 °C and 90 °C in 5°C. 
 
II.2.6 Gel Electrophoresis Experiments 
 HewL samples were analyzed using sodium dodecyl sulfate polyacrylamide gel 
electrophoresis (SDS PAGE) using 10–20% gradient Tris-tricine 12 lane gels (Criterion, Bio-
Rad) and a sodium dodecyl sulfate (SDS) running buffer without glycine. An aliquot of 20 μg 
was mixed with Laemmli sample buffer (Bio-Rad) with or without reducing agent (β-mercapto-
ethanol). Samples were brought to 90ᵒC for 5 min, loaded onto precast gels, and stained with 
BioSafe Coomassie (Bio-Rad) per manufacturer‘s instructions. For assessing the extent and time 
course of lysozyme hydrolysis we incubated 1 mg/ml lysozyme solutions at pH 2.0 and 50 ◦C for 
0 to 120 h under either oligomer-free filamentous (50 mM NaCl) or oligomeric (175 mM) fibril 
growth conditions. The distribution of lysozyme fragments in solution and the extent of overall 
hydrolysis were determined using both non-reducing and reducing SDS gel electrophoresis. 
 
 
 
 
 
27 
 
 
 
III. HEN EGG WHITE LYSOZYME 
 
III.1 Hen Egg White Lysozyme Biophysical Characteristics 
 Human lysozyme was first discovered by Fleming in 1922 in the nasal secretions of a 
patient suffering from acute coryza, and it drew his attention by exhibiting certain bacteriolytic 
properties
137
. Soon it was discovered that its hen egg white homologue (HewL) is easily 
accessible and researchers started to focus on HewL as a main research target in enzymology
138
. 
Its complete primary sequence was determined in 1963
139
, while its three-dimensional structure 
was solved in 1965 by Blake and his team 
106
. This made HewL the first enzyme to have its 
structure resolved by X ray diffraction
107
. The same team also investigated the activity of 
HewL
124
, and in 1969 the catalytic mechanism of the enzyme was proposed
143
. HewL is a 129 
amino acid protein, with a molecular weight of 14.3 kDa, and an isoelectric point of about 11.3. 
It has 6 tryptophans, which allow accurate determinations of its solution concentrations using 
UV absorption at 280 nm
49,122
 , one tyrosine and 2 phenylalanines which allow studies using 
circular dichroism spectroscopy and eight cysteines forming 4 disulfide bonds, conferring an 
extraordinary stability to the molecule
52,145,fig. 2
. HewL‘s 3D structure is comprised of two main 
sections with one section containing extended portions of alpha helices while the other section 
contains mainly the disordered and beta sheet portions of the protein. Based on its 
crystallographic structure its secondary structure is 41% alpha-helical, with 7 helices spanning 
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53 residues , has 10% beta sheet content incorporating 14 residues, while the rest is comprised of 
disordered portions, beta turns or remains unassigned
145
 (fig. 3 ). 
 
(a) 
              
(b) 
 
    
 
 
 
Figure 3. Hen Egg White Lysozyme Native Structure. (a) 3D ribbon diagram structure given 
by X-Ray crystallography data (b) amino acid composition and associated secondary structure
145
. 
Figure adapted with permission from Protein Data Bank open source [PDB code 5L9J]  
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It has been shown that a combination of low resolution structural techniques (CD, FTIR, and 
Raman Spectroscopy
127,128
) can yield reliable data on the secondary structure content of HewL. 
This allowed extensive studies of HewL structural changes induced by solution conditions (pH, 
temperature, pressure, ionic strength) or chemical modifications
122,146–148
. 
(a) 
 
(b) 
 
(c) 
 
Figure 4. Hen Egg White Lysozyme Secondary and Tertiary Structure at pH 2 and pH 7 
(a) Denaturation Curve of 0.15 mg/ml HEWL, pH2 (black), 50 mM NaCl measured using CD 
and 5 µg/ml HEWL pH7 (red) no salt measured using Trp fluorescence (b) secondary structure 
of HEWL at pH 2 (black) and pH 7 (red) measured with CD; (c) FTIR spectra of fresh 
monomers at pH 2 (black) and pH 7 (red). 
 
III.2 Hen Egg White Lysozyme Link to Familial Amyloidosis 
 The ability of human lysozyme to undergo amyloid aggregation was described by Pepys 
in 1993 when it was detected that point mutations of the wild type human lysozyme (threonine to 
isoleucine at position 56 (Thr56Ile) or histidine to aspartic acid at position 67 (His67Asp)) were 
associated with familial non-neuropathic amyloidosis
149
. The first clinical study of this 
amyloidosis was performed by Gillmore et al. in 1999 showing that kidney failure from amyloid 
depositions was the main pathological feature. Liver and gastrointestinal system were affected to 
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a less degree, and in sharp contrast to other non-neuropathic amyloidosis, the heart was not 
affected. Patients are expected to live an average of 20 years after diagnosis
150
. Recently, a new 
type of mutation from arginine to tryptophan in position 82 has been discovered. This 
amyloidosis affects primarily the gastrointestinal system
151.
 Today, there are 8 points mutations 
in human lysozyme known to induce amyloidosis (including the ones mentioned above): 
Ile56Thr, Asp67His, Phe57Ile, Trp82Arg, Trp64Arg, Thr70Asn, Asp68Gly, Trp112Arg
151
. 
Studies on structural stability of 4 out of 8 mutants (Ile56Thr, Asp67His, Phe57Ile, Trp64Arg) 
disease-related variants showed that they are characterized by the reduced thermal stability, 
which potentially renders them aggregation prone
137,138 
. Comparable thermal destabilization of 
wild type lysozyme under denaturing conditions, such as low pH and elevated temperatures, 
similarly induce amyloid formation in vitro. It is interesting to notice that 7 out of these 8 disease 
related point mutations affect the portion of lysozyme that has been shown to become part of the 
amyloid core
154
, while the mutation at position 112 introduces steric stress by placing two 
tryptophans next to each other.  
After Krebs et al. showed that full length, unreduced HewL can form amyloid fibrils under 
denaturing conditions
155
, HewL became a valuable model for studying amyloid fibril formation 
in vitro. HewL has a 60% homology with the primary sequence of the human lysozyme
156
 but its 
secondary and tertiary structure is essentially identical to that of human lysozyme (fig. 5).  
Multiple research groups have characterized the amyloid species formed by HewL under various 
denaturing solution conditions. As for native HewL, low and high resolution techniques such as 
X-ray diffraction, circular dichroism spectroscopy (CD), Fourier Transform Infrared 
Spectroscopy (FTIR) as well as ThT and Congo Red responses have yielded structural 
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information about HewL amyloid fibrils, as well as for various oligomeric and curvilinear 
intermediates
34,131,139,140,142–144
.  
(a) 
 
(b)  
 
Figure 5. Structural Homology of Hen Egg White and Human Lysozyme. (a) HewL (green) 
and Human Lysozyme (grey) structures superimposed using PyMol (b) the 57-107 amino acid 
sequence of HewL (red) that has been shown to become a part of amyloid fibril core upon 
aggregation
154
 Region was highlighted using PyMol. Source files for structural information were 
taken from Protein Data Bank open source [3FE0, 5L9J] 
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IV. RESULTS 
 
IV.1 Hen Egg White Lysozyme’s Two Assembly Pathways: Kinetics, Morphologies and  
 Spectral Properties   
 Our lab has carefully characterized the conditions under which various amyloid aggregate 
species of HewL form in in vitro growth conditions. Using SLS/DLS (static light 
scattering/dynamic light scattering) and AFM, we determined that for fixed protein concentration 
(1.4 mM) and fixed pH and temperature (pH 2 and 50    HewL can undergo amyloid fibril 
formation via two different pathways.
1
  
At low ionic strength (0 -150 mM NaCl), aggregation followed the Nucleated Polymerization 
(NP) kinetics as seen by SLS. Under these conditions, nucleation of the fibril seeds requires an 
extended lag period of many hours to days. Following nucleation, the polymerization 
(elongation) period is characterized by relatively modest increase in SLS. We did not observe an 
equilibrium plateau with SLS, since the samples at our high protein concentrations formed clear 
gels after growing for several days (fig. 6a). This pathway also has a unique DLS signature. 
There is an extended lag period of several days when DLS only detects the monomer, having a 
hydrodynamic radius of 1.9   0.4 nm (fig. 6b, table 4). Immediately after the nucleation event, 
which is characterized by large fluctuations in SLS intensity and emergence of long tails in the 
correlation function, one observes an almost simultaneous appearance of two separate aggregate 
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peaks having radii around 30 nm and 300 nm respectively (fig. 6b). This aggregation kinetics 
were correlated with AFM images of samples taken at different time points along the aggregation 
process. Prior to nucleation, no aggregate species were detected (fig. 6c, table 4). Shortly after 
nucleation, straight, unbranched fibrils several micrometers long are observed with cross-
sections close to those of monomers. This suggests that fibrils polymerize by monomer addition 
(fig. 6d, table 4). At the late stages of aggregation, fibrils underwent lateral assembly into larger 
twisted fibrils. We refer to this pathway as the oligomer-free pathway and the aggregates formed 
as rigid fibrils (RF). 
(a) 
 
 
 
(b) 
 
 
 
 
 
 
 
 
 
Figure 6: Static Light Scattering, Dynamic Light Scattering and Atomic Forces Microscopy 
Signatures of Rigid Fibrils Growth (Continued on Next Page) 
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(c) 
 
 
 
(d) 
 
 
 
 
 
 
 
Figure 6. Static Light Scattering, Dynamic Light Scattering and Atomic Forces Microscopy 
Signatures of Rigid Fibrils Growth. (a) SLS signature RF growth at 20 mg/ml HewL, 50 mM 
NaCl, pH 2, 52ᵒC . Notice the long lag period ended by a sudden upswing indicating the RF 
nucleation event (b) particle sizes given by DLS during aggregation under RF growth. Notice the 
small monomeric peak during the lag period followed by a bimodal aggregate peak distribution 
characteristic for RF growth after nucleation (c) monomers observed during the RFs lag period 
(d) vs. rigid fibrils in the late stages of aggregation under RFs regime. Scale bar indicates 50 nm 
for (c) and 500 nm for (d). 
At intermediate ionic strengths (150 – 350 mM NaCl), there is no signs of a nucleation event in 
SLS and SLS intensity is undergoing a steady and accelerating increase (fig. 7a). DLS showed 
hydrodynamic radius of 2-2.4 nm near the monomeric peak that, prior to nucleation, underwent a 
subtle increase by 0.5 to 1 nm. In contrast to both SLS and ThT fluorescence, DLS detects a 
nucleation event resulting in the appearance of a single aggregate peak around 20 – 30 nm that 
steadily increases in size to 50 – 60 nm (table 4, fig. 7b). The samples gelled in a few days, so 
SLS and DLS monitoring was stopped. AFM images taken during the aggregation process 
showed small oligomers with volumes roughly corresponding to eight monomers after 3 hours 
(fig. 7c). and the nucleation event seen in DLS coincided with the polymerization of these 
oligomers into curvilinear fibrils (fig. 7d). We refer to this pathway as the oligomeric pathway 
and the aggregates formed are amyloid oligomers and curvilinear fibrils (O/CF). 
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(a) 
 
 
 
(b) 
 
 
(c) 
 
 
 
(d) 
 
 
 
 
 
 
 
 
 
 
 
Figure 7. Static Light Scattering, Dynamic Light Scattering and Atomic Forces Microscopy 
Signatures of Oligomers/Curvilinear Fibril Growth . (a) The SLS for 20 mg/ml HewL 250 
mM at 52ᵒC starts to increase immediately upon reaching the denaturing temperature, and no 
feature indicates the polymerization of oligomers into CF. (b) particle sizes given by DLS during 
aggregation under O/CF growth conditions in (a). Upon denaturation, a broad distribution of the 
monomeric peak is noticed hinting at the presence of small oligomers (bottom panel). At later 
times, a second peak corresponding to CF appears (c) small oligomers and occasional small 
curvilinear fibril formed in the beginning of aggregation O/CF growth (d) late stage curvilinear 
fibril grown in the O/CF regime presented in part (a). Scale bar indicates 500 nm  
36 
 
At high ionic strength (400 mM NaCl), disordered precipitate formed immediately upon 
incubation, as indicated by run-away SLS intensities and confirmed by AFM imaging. We refer 
to this region as precipitation (Ppt) and the aggregates formed are amorphous aggregates. 
Table 4. Summary of Rigid and Oligomers/Curvilinear Fibrils Morphologies Determined 
by Atomic Forces Microscopy  
Monomeric Fibril 
Assembly 
Height 
(nm) 
Width 
(nm) 
Cross-section 
(nm
2
) 
Volume 
(nm
3
) 
Monomer (init.) 1.9 ± 0.4 
4.8 ± 0.8 / 3.1 ± 0.8 
(*)
 
10.9 ± 2.4 22.6 ± 7.7 
Monomer (pre-nucl.) 2.1 ± 0.4 
5.5 ± 0.9 / 4.0 ± 1.0 
(*)
 
9.1 ± 1.8 24.2 ± 8.5 
Rigid Filaments 2.4 ± 0.4 5.5 ± 0.6 10.4 ± 2.1  
Rigid Mature Fibril 5.4 ± 0.3 7.2 ± 0.9 30.5 ± 4.3  
     
Oligomeric Fibril 
Assembly 
Height 
(nm) 
Width 
(nm) 
Cross-section 
(nm
2
) 
Volume 
(nm
3
) 
Monomer 3.0 ± 0.2 3.8 ± 0.8 9.0 ± 2.0 22.7 ± 7.0 
Oligomer 3.9 ± 0.1 9.5 ± 1.0 29.1 ± 3.2 184 ± 27.6 
Oligomeric/Curvilinear 
Fibrils 
3.9 ± 0.3 9.5 ± 1.7 29.1 ± 5.5  
(*) || vs ζ to AFM scan direction 
Table adapted with permission from Hill et al. PLoS ONE, 2011,6(4): e18171, table 152 
The same pathways were identified when salts other than NaCl were used, and for both divalent 
anions and cations. This confirmed that the ionic strength was a dominant control parameter of 
the assembly pathway, and non-specific charge screening by salt ions represented the dominant 
mechanism driving the transition from rigid to oligomeric oligomer and curvilinear fibril 
formation. A counterintuitive finding about HewL aggregation was that the net two body 
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interaction of the monomers in solution under fibrillar growth conditions were repulsive, which 
is exactly opposite to conditions promoting protein crystallization
159,160
. Given that at pH 2 the 
net charge on HewL is +15e, we put forward the hypothesis that at this pH and range of ionic 
strengths, the electrostatic charge-charge repulsion would be the force to dominate two-body 
interactions. In 2011, our lab established that the second virial coefficient obtained via SLS 
measurements was positive (indicating indeed a net repulsive interaction) and decreased as salt 
concentration was increased, indicating the decrease in net repulsion. At 400 mM NaCl where 
amorphous precipitation occurred the second virial coefficient was close to zero (fig. 8a.)
52
. 
Furthermore, the second virial coefficient together with the two-body interaction parameter 
determined based on these experiments indicated that the balance between net repulsive and 
attractive interactions had a clear correlation with the morphology and kinetics signatures of the 
amyloid assemblies of HewL at pH2 (fig. 8b). 
(a) 
 
 
(b) 
 
 
Figure 8. Debye Ratio and Interaction Parameter for HewL Monomers at pH 2, 20ᵒC. (a) 
Notice the positive slope corresponding to the second virial coefficient which indicates a net 
repulsive force. (b) the interaction parameter calculated based on data from (a) show a clear 
decrease of net repulsion as ionic strength of the solution increases and the morphologies transit 
from rigid fibrils to oligomers/curvilinear fibrils and then to precipitates. Table adapted with 
permission from Hill et al. PLoS ONE, 2011,6:4: e18171, figure 5a,b52 
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Overall, these observations indicate that the aggregation pathway, their kinetics and 
corresponding aggregate morphologies were regulated by the effects of charge screening on both 
the structure of the monomeric protein and intermolecular interactions between the monomers.  
 
IV.2 Hen Egg White Lysozyme Aggregates’ Structures and Their Time Evolution 
 In this section I describe how we synchronized our kinetics and topological 
measurements of HewL aggregates growth with FTIR and thioflavin T dye to obtain structural 
information on different types of aggregates. 
 
IV.2.1 Probing Hen Egg White Lysozyme Aggregates’ Structures and Their Time   
 Evolution Using Fourier Transform Infrared Spectroscopy  
 Beyond characterizing HewL aggregation pathways, aggregate morphologies and 
kinetics, we also investigated their structural characteristics. Structural analysis of aggregates 
was performed using FTIR and ThT and correlated to the kinetics of fibril growth (DLS/SLS) as 
well as to changes in aggregate morphology (AFM)
118
. As a reference, FTIR spectrum of 
monomeric HewL under growth conditions were acquired and deconvoluted. Results were 
compared with reported literature values as control of both the experimental protocol and the 
data analysis. We opted for a conservative deconvolution using a minimal number of mainly α-
helix and β-sheet peaks to fit the spectrum. The α-helix peak was located at 1655 cm-1 and the 
combined β-sheet peak at low frequencies was found ~1620 cm-1, as determined from the second 
derivative of the spectrum. We found good agreement for the ratio of α-helix to β-sheet content 
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with that reported in the literature
122
 (fig. 9a). FTIR spectra of both the end stage rigid fibrils 
(RF) grown at low ionic strength, as well as curvilinear fibrils (CF) grown at high ionic strength 
exhibited distinct peaks in their Amide I bands around 1620 cm
-1
 
158,161
. Peaks in this region of 
the Amide I band are considered ―diagnostic‖ of amyloid hydrogen bonding158. Despite the 
similarities in the FTIR spectra of the RFs and O/CF, their amyloid peak positions showed a 
subtle, but consistent shift: 1623 cm
-1
 for RF and 1619 cm
-1
 for O/CF (fig. 9b,c, fig. 9a ). The 
pattern of shifting the intermolecular β-sheet (~1620 cm-1) band to lower wavenumbers 
compared to native ones (1635 cm
-1
) has been notices for several proteins as well as the rigid 
fibrils band being at consistently higher wavenumbers that the curvilinear/oligomers band (see 
the table Appendix B.3.2). In order to asses if the subtle differences in intermolecular β-sheet 
position of RF and O/CF are reproducible, we took the difference of normalized spectra; i.e., we 
subtracted point by point the aggregate‘s spectra from the initial, monomeric spectrum. As can 
be seen in figure 10b, difference spectra confirm the 1623 ± 1 cm
-1
 peak for RF and 1618 ± 1 cm
-
1
 peak for O/CF. These observations are consistent with results for human lysozyme fibrils and 
oligomers grown under similar solution conditions (see table 3). Also, from figures 9b,c and 10b 
it is easy to see that the intermolecular β-sheets forms at the expense of HewL‘s α-helices for 
amyloid aggregates in both pathways. 
The FTIR spectra of HewL aggregates confirm that, at the end point of kinetics experiments, the 
aggregates contain amyloid-like -sheet peaks in the 1610-1630 cm-1 band, but leaves open the 
question when during the aggregation process this structure emerged. Based on SLS/DLS and 
AFM data, RFs form directly via Nucleated Polymerization; i.e., their structure forms from the 
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(a) 
 
 
 
 
Figure 9 Infrared Spectra of 
Late Stage Fibrils in Either 
Pathway Show Distinct β-sheet 
Peaks. Amide I spectrum for (a) 
native lysozyme in buffer at pH 
2.0, and for (b) oligomer-free or 
(c) oligomeric fibrils analyzed 
after incubation. Black lines 
represent the raw spectra while 
gray lines indicate the gaussian 
decomposition of the spectra into 
α-helix, β-turn, and β-sheet 
components as well as the 
resulting overall fit to the raw 
spectra. The bar graphs to the 
right of each spectrum represent 
the relative amplitudes of the α-
helix and β-sheet peaks derived 
from spectral. In order to avoid 
monomeric contributions to the 
spectra, monomers were separated 
from the aggregates by 
centrifugation through 50 kDa 
cut-off filters. Figure adapted 
with permission from Foley et al., 
Journal of Chemical Physics., 
2013, 139(12):121901, figure 2 
(shared first authorship) 
(b) 
 
(c) 
 
 
start. In contrast, the structural evolution of β-sheet content in oligomers and curvilinear fibrils is 
not known. Therefore we decided to monitor the development of the intermolecular β-sheets 
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content as function of incubation period. Figure 10c shows that the amyloid-related β-sheets 
motif can be detected in FTIR spectra as early as 4 hours after the incubation when DLS showed 
no presence of CF yet.  
(a) 
 
 
(b) 
 
(c) 
 
Figure 10. Amide I Spectra and Their Time Evolution for Lysozyme Undergoing 
Oligomeric Fibril Growth. (a) Amide I spectra of monomers at pH 2 (black curve), RFs grown 
at 20 mg/ml (1.4 mM) HewL, 50 mM NaCl, pH2, 52 , separated through a 50 kDa cut-off filter 
(red curve) and O/CFs grown at 20 mg/ml HewL, 200 mM NaCl, pH 2, 52 , separated through 
a 50 kDa cut-off filter (blue curve) (b) Corresponding FTIR difference spectra of the Amide I 
region for oligomer-free fibrils (red curves) and for oligomeric protofibrils (blue curves) at pH 
2.0. The two difference spectra for oligomer-free fibril growth are for samples either incubated 
for multiple days (solid red curve) or derived from rapid growth (<12 h) via seeding with pre-
formed fibrils (short-dashed red curve). Similarly, oligomeric difference spectra are shown for 
growth with 175 mM NaCl (solid blue curve), during rapid growth (<3 h) in 325 mM NaCl 
(short dashed blue curve), or for growth at pH 7/ 65 °C (blue dotted curve) (c) Temporal 
evolution of the Amide I difference spectra for lysozyme undergoing fibril growth along the 
oligomeric pathway. Figure adapted with permission from Foley et al., Journal of Chemical 
Physics., 2013, 139(12):121901, figure 3 (shared first authorship) 
 
IV.2.2 Time Evolution of Aggregates’ Structure Using Thioflavin T  
 To characterize further the structural evolution of amyloid aggregates in both pathways 
we incubated solutions forming aggregates in each pathway, extracted aliquots at different time 
points and measured their ThT response. ThT is a fluorescent dye that recognizes amyloid beta 
sheet motifs in different amyloid fibrils, as well as other naturally occurring, non-disease related 
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protein fibers
12–14
. There is a remarkable difference in SLS vs. ThT responses in each pathway 
(fig. 11). During RFs growth ThT undergoes a nearly 100 fold increase in fluorescence intensity, 
but its response to curvilinear fibrils is an order of magnitude lower, and it shows virtually no 
response to precipitates (fig. 11). ThT response clearly follows the shape of the kinetic curves for 
rigid fibrils and curvilinear fibrils growth respectively (fig. 11 a,b top). For rigid fibrils, both 
SLS and ThT showed no increase during the lag period, and a sudden increase upon fibril 
nucleation, with the increase in ThT fluorescence being 40 fold higher initially (fig. 11 a). This 
behavior is also consistent with DLS measurements for aggregation behavior under RF solution 
conditions, where no discernable aggregated populations are detected during the lag period and 
the nucleation event is sudden and characterized by the (almost) simultaneous emergence of a 
double aggregates peak (fig. 11a bottom). This pattern of correlated SLS/ThT fluorescence 
behavior was noticed for several solution conditions for RF growth, strongly indicating that this 
is a general characterization of RF growth kinetics (fig. 11a top, bottom). For curvilinear fibrils, 
in contrast, both SLS and ThT increase from the start which corresponds to oligomer formation, 
but no sudden changes in ThT fluorescence occurs as DLS indicates that the oligomers start 
polymerizing into curvilinear fibrils (fig. 11b). Again, the pattern of correlated SLS/ThT 
fluorescence behavior was noticed for several solution conditions for aO/CF growth strongly 
indicating that this is a general characterization of RF growth kinetics (fig. 11b top, bottom). 
This serves as evidence that there is no significant restructuring of oligomers as they assemble 
into curvilinear fibrils and polymerization did not result in any additional restructuring, gain or 
loss of amyloid motifs recognized by ThT. Based on ThT and FTIR data, we decided to call 
oligomers (Os) as amyloid oligomers (aOs). 
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(a) 
 
(b) 
 
(c) 
 
(d) 
 
Figure 11. Thioflavin T Response to Hen Egg White Lysozyme Aggregation Kinetics. (a) 
(top) Relative changes in ThT fluorescence intensity () and light scattering intensity ( ) 
measured for a solution undergoing fibril growth under RFs growth conditions (6a bottom 
sample). The sudden upswing in both ThT fluorescence and light scattering intensity coincides 
with the nucleation of rigid fibrils detected by dynamic light scattering. ) (bottom) Temporal 
evolution of aggregates obtained from dynamic light scattering for a solution undergoing fibril 
Figure 11: Thioflavin T Response to Hen Egg White Lysozyme Aggregation Kinetics 
(Continued on Next Page) 
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growth under RFs growth conditions (50 mM NaCl). The plot shows a characteristic monomer 
peak ( Rh = 1.9   0.4 nm) during the lag period until suddenly two additional aggregate peaks 
emerge with peak radii near 300 nm and 30 nm, respectively. (b) (top) Relative changes in ThT 
fluorescence intensity () and light scattering intensity (○) measured from the same sample. For 
CFs growth, both ThT fluorescence and light scattering intensity show a continuous increase, 
with no sudden changes in behavior upon CFs polymerization seen in DLS. (bottom) Temporal 
evolution of the particle size distribution obtained from DLS for a solution undergoing O/CFs 
under monomeric O/CFs conditions (175 mM NaCl). The slow increase of Rh of the monomer 
peak indicates the formation of small populations of oligomers. The aggregate peak at approx. 30 
nm emerging around 15 hrs indicates the formation of CFs polymerized from oligomers. (c) Log-
log plot of the fractional changes in ThT fluorescence vs. light scattering intensity for multiple 
lysozyme samples incubated under conditions resulting in RFs growth (solid symbols), CFs 
growth (open symbols) or high salt concentrations inducing amorphous precipitation (crosses). 
The dashed lines represent linear fits through the data. In all cases, ThT/SLS ratios display strong 
and persistent linear correlations throughout the entire growth process. (d) fractional changes in 
ThT fluorescence with respect to light scattering intensity as a function of salt concentration. 
Notice that salt does not qualitatively affect the ratio. Insert: ThT fluorescence of a fresh 1.3 mM 
HEWL sample at pH2 as a function of NaCl concentration. Notice that over a 400 mM NaCl 
span, there is a double in ThT fluorescence most probably due to viscosity increase
117
. Figure 
adapted with permission from Foley et al., Journal of Chemical Physics., 2013, 139(12):121901, 
figure 5,6,8 (shared first authorship) 
 
IV.2.3 Investigation of Hydrolysis on Aggregate - Specific Thioflavin T Response  
 The observed differences in the structure of different amyloid species raise the question 
whether those differences arise from different monomeric states being incorporated into RFs than 
into O/CFs. Given that solution conditions (pH 2 and 52 ᵒC) favor hydrolysis147,162, if hydrolysis 
is salt dependent, differences in O/CF and RF structure could have roots in this dependence. 
However, as can be seen from figure 12a, hydrolysis does not depend on salt. RFs and O/CF 
successfully incorporate the same monomeric states, and structural differences are driven by 
assembly mechanism rather than by monomeric state distributions. Additionally, we addressed 
whether pathway-specific differences in ThT responses arose from the differences ingrowth 
conditions or from binding to hydrolyzed HewL monomers. Toward that end, we measured with 
ThT and FTIR HewL aggregates growth near physiological conditions (pH 7, elevated 
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temperature). DLS and AFM images of aggregates formed at pH 7 show that aggregation follows 
the oligomeric assembly pathway (data not shown, but can be seen in detail in Mulaj et al
163
). 
Upon comparison between figure 11b top and Figure 12b it is evident that ThT/SLS ratio reveals 
very similar patterns and no detectable restructuring of oligomers occurs as they assemble into 
curvilinear fibrils. This served as confirmation that structural evolution of aggregates formed 
along oligomer-free and oligomeric pathways is independent of hydrolysis effects. These results 
reinforce the early obtained by FTIR where we showed that the intermolecular β-sheets is 
present in oligomers and does not undergo any detectable transformations upon polymerization 
into CF. 
(a) 
 
(b) 
 
Figure 12. Hydrolysis Effects on Pathways and Thioflavin T Response During Kinetics 
Measurements. (a) Reducing SDS PAGE gel of HEWL monomers incubated at pH 2, 52 , at 
50 mM and 175 mM NaCl. At each time step, the right lane corresponds to growth at50 mM and 
the left lane to 175 mM NaCl. The extent of hydrolysis is independent of ionic strength (b) ThT 
and light scattering ratios measured for fibril growth of lysozyme at physiological pH (pH 7, 20 
mM NaCl, T= 65 ᵒC). Notice the striking resemblance of ThT and SLS at pH 7 (in absence of 
hydrolysis) and pH 2 (in presence of hydrolysis). Figure adapted with permission from Foley et 
al., Journal of Chemical Physics., 2013, 139(12):121901, figure 4,8 (shared first authorship) 
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IV.3 Kinetic Phase Diagram and Critical Oligomer Concentration (COC) 
 This section describes how I mapped the HewL amyloid aggregates phase diagram via 
kinetic experiments in the HewL vs NaCL concentration phase space. I have identified three 
main regions where either RF, aO/CF or PPt were the kinecally favored aggregate. The boundary 
between RF and aO/CF is sharp and it has been named Critical Oligomer Concentration (COC), 
while PPt are just kinecally arrested aO/CF. Also, via cross-seeding experiments we determined 
that RF are the thermodynamically stable phase, while aO/CF are metastable, long-lived 
oligomeric species. Further, in collaboration with Dr. Schmit from Univeristy of Kansas, we 
showed that a charged colloidal model captures the main parameters of aO/CF formation as a 
high order kinetics, electrostatically driven phase transition. 
 
IV.3.1 Mapping the Hen Egg White Lysozyme Amyloid Phase Diagram  
 The main motivation for the subsequent experiments was to determine whether there are 
well defined ―transition boundaries‖ delineating the formation of either rigid fibrils or oligomers 
and curvilinear fibrils. Specifically, I wanted to explore whether charge effects (protein charge 
and salt-mediated charge screening) would explain such transitions. Utilizing the distinct 
SLS/DLS and ThT kinetic signatures of HewL amyloid aggregates grown in different pathways, 
I therefore mapped out the aggregation behavior of HewL solutions protein concentrations, 
covering a range of monomer concentrations from 6 μM to 1.4 mM, and ionic strengths (50−800 
mM NaCl) while fixing fixed pH (= 2) and temperature (= 52 ᵒC). Figure 13 describes the main 
criteria used to determine the assembly pathway from growth kinetics observed at a given protein 
and salt concentration 
138
. SLS/DLs and ThT kinetics were used to determine the pathway-
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specific kinetics, while AFM was used to confirm aggregate structure near the boundary were 
kinetics becomes ambiguous.  
(a) 
 
(b) 
 
(c) 
 
Figure 13. Morphology and Kinetics of Rigid Fibrils, Oligomers, Curvilinear Fibrils and 
Precipitates Formed by Hen Egg White Lysozyme. Summary of the distinct morphologies and 
kinetics signatures associated with growth of (a) rigid fibrils (RF) (b) oligomers and curvilinear 
fibril (O/CF) and (c) precipitation (Ppt) of HewL under partially denaturing conditions (pH 2, T 
= 52 °C). The first column displays atomic force microscopy images of RFs (50 mM NaCl), CFs 
Figure 13: Morphology and Kinetics of Rigid Fibrils, Oligomers, Curvilinear Fibrils and 
Precipitates Formed by Hen Egg White Lysozyme (Continued on Next Page) 
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200 mM NaCl) and Pps (400 mM NaCl). Black scale bar in all images represents 300 nm. 
Aggregate heights in all images are indicated by false-color, with the corresponding scale given 
below the bottom image. The subsequent columns show representative thioflavin T (ThT) 
responses, static light scattering intensities (SLS) and particle size distributions/ autocorrelation 
functions measurements with dynamic light scattering (DLS). RF growth displays a clear lag 
period in all three signals. RF nucleation causes the formation of two separate aggregate peaks in 
DLS, the sizes of which remain essentially stationary. Oligomer formation and subsequent CF 
nucleation and growth produce continuous increases in ThT and SLS. CF nucleation only 
generates one aggregate peak and does not yield a discernible discontinuity in ThT or SLS 
responses. Precipitation, in turn, induces rapidly saturating ThT and SLS signals, with the 
corresponding DLS autocorrelation functions exceeding conditions suitable for size analysis
164
. 
Figure adapted with permission from Miti et al., Biomacromolecules, 2015, 16 (1), pp 326–335, 
figure 1 
 
The resulting HEWL amyloid phase diagram is given in figure 14. Each point in the diagram 
corresponds to the results from multiple kinetic measurements at these solution conditions. Rigid 
fibrils (RF) are the sole aggregated phase in the range of low salt or low protein concentrations 
covered in our experiments. As we increased either the ionic strength or protein concentration, 
amyloid growth abruptly switched to yield amyloid oligomers, with their subsequent 
polymerization into curvilinear fibrils (aO/CF). We labeled this sharp boundary between the two 
aggregated amyloid phases ―critical oligomer concentration‖ or COC because of its resemblance 
to the critical micelle concentration (CMC) in surfactant systems. As either protein or salt 
concentrations were pushed to higher values, the solution formed amorphous precipitates (Ppt) 
due to high aggregation driving force. Similar to the determination of the COC, we were able to 
determine experimentally a boundary between the aO/CF phase and the Ppt, but given the fast 
kinetics and the limitations of the methods used, we must consider this boundary subject to larger 
systematic errors than the COC. 
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(a) 
 
(b) 
 
Figure 14. Kinetics Phase Diagram for Rigid Fibrils, Oligomer and Curvilinear Fibrils and 
Precipitate Formation of Hen Egg White Lysozyme (a) linear scale: Kinetic Phase diagram of 
amyloid aggregate species for hew-L undergoing amyloid growth as function of protein and 
NaCl concentrations at pH 2, T = 52 °C. Orange dots (•) represent growth of rigid fibrils (RF), 
blue dots (•) indicate oligomer and/or curvilinear fibril (aO/CF) formation while dark blue dots 
(•) signify precipitation (Ppt). Aggregate species obtained at a given combination of protein and 
salt concentration was typically determined from multiple kinetics measurements using ThT, 
SLS and DLS. Dashed lines are guides to the eye highlighting the well-defined transitions 
between the three distinct regions in this phase space for each of the three aggregate species. (b) 
the same data as in part (a), but on logarithmic scale. Figure adapted with permission from Miti 
et al., Biomacromolecules, 2015, 16 (1), pp 326–335, figure 2. 
 
 
IV.3.2  Amyloid Oligomer and Curvilinear Fibrils Share a Common Transition Boundary 
 There are three morphologically distinct aggregates that emerge past the COC: amyloid 
oligomer, CF, and Ppt. Below the precipitation threshold, the formation of CF is separated from 
the onset of oligomer formation by a lag period. This nucleation barrier implies that oligomer 
concentrations need to exceed an, as yet unknown, solubility limit for CF. We set out to establish 
this solubility boundary by seeding solutions with preformed CF and then delineating the 
conditions for the transition from growth to decay. At high protein/low salt concentrations, 
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preformed CF were diluted into a series of solutions at fixed HewL concentration but decreasing 
salt molarity (fig. 15a). Conversely, for low protein/high salt concentrations, CF seeds were 
diluted with different amounts of buffer solution at fixed salt concentration (data not shown). 
Using DLS, growth and decay rates of the CF peaks were monitored and extracted from 
exponential or linear fits to the peak intensities versus time. CF solubility was taken as the 
extrapolated point where CF growth switched over to decay. Within experimental error, CF 
solubility matched the COC, and we therefore refer to this region by the single acronym aO/CF. 
This also implies that oligomers under these conditions will always form CFs over time. Despite 
the polymerization of aO into CF, we have found earlier that there is no detectable restructuring. 
These data combined suggests that aO polymerization would have no energetic barrier to 
overcome. 
 
IV.3.3 Amyloid Oligomers and Their Curvilinear Fibrils Are Thermodynamically   
 Metastable. 
 The diagram indicated that amyloid aggregate species have well defined regions of phase 
space where they are the kinetically favored state. This, however, does not determine whether 
these phases are thermodynamically stable or whether some are metastable. In order to establish 
this, we seeded RFs grown below the COC into conditions above the COC. If RF decay upon 
crossing the COC, then both RFs and aO/CF represent the thermodynamically stable states in 
their respective growth regimes. If RF decay when seeded above the COC, then RF represents 
the thermodynamically stable state throughout the entire region. Separated RFs grown under 
solution conditions (see I.1.4), where they are the kinetically favored state, were cross seeded 
into fresh monomeric solutions promoting aO/CF growth (RF above the COC). As can be seen 
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from figure 15c and b, RF continued to grow even above the COC. This showed that RFs are the 
stable state, while O/CF are a metastable aggregate phase. I have also confirmed with AFM 
imaging (data not shown) at a later time that the predominant aggregate species just after 24 
hours is RF. 
 
IV.3.4 Precipitation Boundary: Structural Analysis via Infrared Spectroscopy 
 Since the phase diagram has a second boundary between the O/CF and Ppt, we wanted to 
investigate whether this was a transition from an amyloid/ phase
107
 to an amorphous monomeric 
aggregate phase or was an independent transition delineating yet another amyloid aggregate 
phase of HewL. FTIR was used to see if there was an underlying structure of Ppt. If Ppt were a 
random aggregation of native monomers we expected that there would be no discernable 
differences in the FTIR spectrum of Ppt from that of HewL monomers. To our surprise, 
precipitates formed at high salt/protein concentrations developed a pronounced β-sheet peak at 
the same wavenumber as aO/CF. The weak peak near 1690 cm
−1
 of O/CF was less prominent for 
precipitates, and the peak near 1655 cm
−1
 suggests that a residual fraction of α- helical structures 
remains. These differences probably arise from the difficulties of separating precipitates from 
their monomeric background via cutoff filters, which is less effective than for aO/CF. 
Nevertheless, the above IR spectra imply that the precipitates share structural characteristics of 
oligomeric amyloids. Their alignment with the aO/CF peak in the Amide I band further implies 
that the precipitates originated via rapid formation and subsequent precipitation of amyloid 
oligomers, and we refer to them from here on out as aO-Ppt. The FTIR spectrum of Ppt indicate 
that Ppt are ta kinetically trapped aO/CF phase (fig. 15d).  
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(a) 
 
(b) 
 
(c) 
 
(d) 
 
Figure 15. Oligomer vs. Curvilinear Fibrils Formation, Metastability of Oligomer Phase 
Against RF Growth and Amyloid Structure of Precipitates. (a) CF seeds grown at Clys = 20 
mg/mL and [NaCl] = 350 mM were subsequently re-suspended into solution with [NaCl] 
increasing from 100 to 300 mM. The transition from growth to decay of CFs occurred at the 
same NaCl concentration as delineated by the COC. These data indicate that there is no barrier 
for oligomer formation and the lack of hysteresis, so, within experimental error, the solubility of 
oligomers is identical to that of CFs. (b,c) RF seeds grown at Clys = 20 mg/mL hew-L and [NaCl] 
= 50 mM, were separated from monomers and seeded at 5 % solution into monomer solutions 
with Clys = 20 mg/mL and NaCl between 100 and 250 mM. (b) Changes in the particle size 
distribution of RFs seeded into 20 mg/mL hew-L monomers at [NaCl] = 250 mM s. Both the 
monomer peak (~ 2 nm) and the two aggregate peaks (short and long rigid RFs) are visible right 
Figure 15: Oligomer vs. Curvilinear Fibrils Formation, Metastability of Oligomer Phase Against 
RF Growth and Amyloid Structure of Precipitates (Continued on Next Page) 
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after seeding (0 hr). With increasing incubation period (10 hrs, 20 hrs), the area under the RF 
peak grows at the expense of the monomer peak with very large aggregates settling out near the 
end. (c) ThT fluorescence responses for RFs seeded into fresh lysozyme (16 mg/mL) at NaCl 
concentrations below (100, 150 mM) and above (175, 200 & 250 mM) the COC. In all cases, 
RFs continue to grow rapidly. (d) Attenuated total reflectance FTIR spectra within the Amide I 
band for amyloid RFs ( ) CFs (○) Ppt ( ) formed under the conditions used to determine the 
phase diagram in Fig. 2. Notice the peaks near 1620 cm
-1
 in all three aggregate spectra, including 
that for precipitates, which are considered diagnostic of amyloid beta-sheets structures. Figure 
adapted with permission from Miti et al., Biomacromolecules, 2015, 16 (1), pp 326–335, fig. 3. 
 
 
IV.3.5  Model of Colloidal Charge Repulsion Reproduces Critical Oligomer Concentration  
 Boundary 
 In order to model our solubility curves and gain a better understanding of the physical 
parameters governing amyloid self-assembly we used a colloidal model that accounts for the 
electrostatic energy cost of confining charged monomers within the volume of an amyloid 
oligomer. Implementation of the model assumptions, derivations of analytical approximations 
and numerical simulations were all performed by Dr. Jeremy Schmit at Kansas State University. 
Within this model, the COC is calculated as the free energy difference between the free energies 
of the individual monomers vs. that of the corresponding oligomer. It accounts for the 
electrostatic repulsive interactions among the monomers, and a non-electrostatic and solution-
independent cohesive energy. The rapid decrease in the COC with increasing salt concentration 
arises from the increased charge screening of the net monomer charge. The calculated solubility 
curve fitted the experimental COC curve very well (fig. 16b). In order to replicate the 
precipitation boundary Dr. Schmit had to assume further that oligomers had asymmetric 
interactions, with end-to-end interactions stronger than equatorial interactions. This fact would 
have remained unnoticed had we not tried to model the aO/CFs to Ppt solubility boundary. The 
ability of a simple theoretical model to capture the complexities of the transition from oligomer-
free to oligomeric amyloid assembly is a strong indication that important aspect of amyloid self-
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assembly are accessible to simplified models of colloidal self-assembly. For further details on the 
theoretical model, please see Appendix A. 
(a) 
 
(b) 
 
Figure 16. Kinetics Phase Diagram for Rigid Fibrils, Oligomer and Curvilinear Fibrils and 
Precipitate Experiment vs. Theory. Kinetics phase diagram of HewL amyloid aggregate 
species as function of protein and NaCl concentrations at pH 2, T = 52 °C. (a) Blue squares () 
and their error bars indicate the experimentally determined COC for HewL amyloid oligomers, 
dark blue squares () represent the onset of precipitation determined experimentally, while the 
solid blue and dark blue lines through the experimental oligomer phase boundaries are based on 
theoretical predictions from the colloidal model. (b) the same data as in part (c) of the graph, but 
on a logarithmic scale, for a better visualization
164
. Figure adapted with permission from Miti et 
al., Biomacromolecules, 2015, 16 (1), pp 326–335, figure 4. 
 
 
IV.4 Hen Egg White Lysozyme Rigid Fibrils Nucleation Mechanisms Above and  
 Below the Critical Oligomer Concentration    
 In this section I describe how I use the phase diagram for HewL amyloid aggregates to 
answer one of the main questions in the field, namely, via which mechanism RF substitute early 
stage aO/CF? there are currently two possible scenarios. One scenario implies an internal 
restructuring of aO/CF into a RF nucleus, while a second possibility suggests that aO/CF are off-
pathway metasble aggregates that do not restructure into a RF nucleus and RF nucleate from 
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monomers undergoing classical nucleated polymerization. We use the predictions on RF lag 
period lengths in this two different scenarios, and use our phase diagram to test this predictions. 
We found that RF undergo nucleated polymerization both in absence and presence of aO/CF. 
Moreover, there are stromg hints that aO/CF actively inhibit RF nucleation. 
 
IV.4.1 Amyloid Nucleation and Growth Kinetics Reflect Basic Aspects of the Amyloid  
 Phase Diagram 
 The phase diagram provides basic insights how RFs will emerge at the end stage of 
amyloid assembly. Based on the phase diagram, the metastable phase of aO/CFs is in equilibrium 
monomer, and would eventually decay back to monomers below their solubility, COC, and. The 
dimensionless super-saturation for aO/CF formation is set by 
     = (     - COC)/COC, 
where COC represents the aO/CF solubility and       represent the free monomer 
concentration. Meanwhile, RFs can nucleate via NP at any point in the phase space above their 
respective solubility, including parts of the phase diagram where aO/CF are the kinetically 
favored state. The thermodynamic driving force for RF nucleation and growth is the 
corresponding supersaturation  
    = (     - SRF) / SRF, 
where       is the free monomer concentration and SRF the fibril solubility. Our experimental 
phase diagram provides an upper bound on SRF of a few micromolar (with SRF itself expected to 
be noticeably smaller).  However, in contrast to aO/CF, the initial growth kinetics of RF is 
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limited by the high barrier for seed nucleation. Using these concepts we can provide a basic 
understanding why amyloid growth will proceed in distinctly different ways above and below the 
COC.  
At solution condition above the COC the initial growth rate for aO/CF is set by aO/CF which 
decreases to zero as monomers are converted into aO/CF and Cmono reaches the COC. While RFs 
have a much lower solubility than aO/CF, their growth is retarded by the high nucleation barrier 
for seed formation. Therefore, aO/CF can be the dominant early-stage aggregate species and 
even deplete monomers down to the COC before any noticeable levels of RF seeds can form (fig. 
17b). Eventually, though, RF will nucleated and begin elongating, thereby depleting monomer 
levels below the COC. Therefore aO/CF will start decaying and RFs will continue to grow until 
all monomers tied up in the aO/CF state are transferred to RF (fig. 17b, c).  
(a) 
 
(b) 
 
(c) 
 
Figure 17. Supersaturation as a Driving Force for Pathway Switch. (a) Schematic 
representation how aO/CF are transformed into the RF state. AFM image of aO/CF and RF are 
representations of commonly observed aggregate species in the aO/CF and RF pathways. Scale 
with initial solution conditions above the COC As aO/CF grow, the monomeric substrate gets 
Figure 17: Supersaturation as a Driving Force for Pathway Switch (Continued on Next Page) 
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depleted and the sample reaches the COC (blue dashed line). As RFs nucleate the monomeric 
substrate gets further depleted toward SRF and the monomeric concentrations drops below the 
COC (red dashed line) where aO/CF can no longer grow or even be stable. (c) The expected 
kinetic signature g of a sample with initial conditions indicated in (b). Notice the rapid growth of 
aO/CF with an eventual slow down and plateau as monomer concentrations reach the COC. A 
second upswing is due to RFs nucleation and their subsequent growth. 
 
This logic is reflected in the growth kinetics as monitored with ThT for solutions below and 
above the COC (fig. 18a and b). Below the COC, RF growth undergoes nucleated 
polymerization. As a result no change occurs to the ThT baseline during the lag period followed 
by a sharp and explosive increase upon RF nucleation (figure 18a). As the free monomer 
concentration is depleted to Cmono ≈ SRF, RF growth ceases and ThT fluorescence comes to a 
plateau. During the lag period detected by ThT no RFs or other pre-nucleation aggregates could 
be detected with AFM (fig. 18a(I), AFM panel aI). After the RF nucleation indicated by ThT, 
long, straight fibrils can be readily observed with AFM (fig. 18a(II), AFM panel aII).  
Above the COC aggregation kinetics displays a different signature. ThT fluorescence increases 
immediately upon incubation and this corresponds with the formation of aO observed in AMF 
images (fig. 18b (I), AFM panel bI). With time, the rate of ThT fluorescence increases slows 
down which is consistent with a decreased driving force for aO formation. Overall aOs tend to 
polymerize into CFs as shown by AFM (fig. 18b(II), AFM panel bII). For monomer 
concentrations well above the COC, aO concentrations reach the plateau as monomer 
concentrations deplete to the COC and before RFs nucleate (fig. 18b). The second increase in the 
ThT fluorescence is associated with RF nucleation and growth (fig. 18b(III), AFM panel b(III) - 
b(V)). RFs grow until the monomeric substrate reaches the fibril solubility SRF. It is important to 
notice that AFM images of CFs in figure 18b AFM panels II and III show long curvilinear fibrils 
and no or very few rigid fibrils while in panel IV and V the same sample shows considerable 
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shortening in curvilinear fibrils length and more rigid fibrils, which is consistent with the 
hypothesis that they undergo decay. 
(a) 
 
(b) 
 
 
(aI) 
 
 
(aII) 
 
 
(bI) 
 
 
(bII) 
 
(bIII) 
 
(bIV) 
 
(bV) 
 
 
 
Figure 18. Growth Kinetics and Aggregate Morphologies Below and Above Critical 
Oligomer Concentration (a) Typical ThT kinetics for amyloid growth below the COC (here: 20 
Figure 18. Growth Kinetics and Aggregate Morphologies Below and Above Critical Oligomer 
Concentration (Continued on Next Page) 
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uM HewL, 500 mM NaCl, pH 2, 52 °C). During an initial lag period lasting from many hours to 
days, ThT emission remains flat. The rapid upswing upon HewL RF nucleation eventually levels 
off as RF growth depletes free monomer concentrations down to SRF. AFM images obtained after 
extended deposition periods yield only monomers during the lag period (aI). Following the 
nucleation event, RFs appear (aII). (b) ThT kinetics for amyloid growth above the COC (here: 
350 µM HewL, 400 mM NaCl, pH 2, 52 °C) correlated to AFM images of aggregate 
morphologies at the indicated time points (b I-V). An immediate increase in ThT kinetics 
coincides with the formation of aOs and CFs (bI, bII). As aO/CF growth depletes monomer 
concentrations back to COC, a plateau phase is noticed followed by the nucleation and growth of 
RFs. The second slow down and plateau-like phase is due to slowing RFs growth rates as 
monomers get depleted again. 
 
IV.4.2 Amyloid Phase Diagram Permits Unbiased Test of On- Pathway Nucleated 
 Conformational Conversion vs. Competitive Nucleated Polymerization 
 As it has been described in the introduction (see I.D), there are several routes the RF 
nucleus can form, most notably via a random encounter of several monomers (NP), or through 
the internal restructuring of early stage aggregates (NCC, fig. 19 right). The RF nucleation 
mechanisms gain relevance in the light of the evidence that for numerous amyloidosis, the early 
stage, oligomeric species are the main culprit, while RF serve as a relatively harmless reservoir 
for the denatured/unstable proteins. Hence, the RF nucleation and growth in the presence of 
oligomeric species has a direct implication for the long term outcome of amyloid diseases. As I 
had shown in the earlier chapters, our HewL system also transitions from early stage aO/CF to 
end stage RF for solution conditions above the COC. This way, besides providing a direct 
rationale for the distinct kinetic signatures of amyloid self-assembly below and above the COC, 
the phase diagram represents a unique tool to inquire whether RF nucleation above the COC 
proceeds via NP from monomer or involves nucleated conformation conversion (NCC) of 
oligomers and curvilinear fibrils. It is notable to point out that the growth kinetic curves alone 
would not be able to discern between the two RF nucleation scenarios. In both cases, aO/CF 
form first as kinetically favored aggregated species, which would correspond to the initial 
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increase in ThT Fluorescence (fig. 19 left, top and bottom). The nucleation and growth of RF 
would be indicated by the second up rise in the ThT kinetics, but there are no indications in the 
fluorescence response on which route the RF nucleus formed. Monitoring the aO/CF after the RF 
nucleation would not give a definite answer as well. As we showed previously, aO/CF are the 
metastable phase, so if RF nucleation and subsequent growth proceed via monomers (NP), 
aO/CF are expected to decay once the monomeric substrate is depleted to concentrations below 
the COC. Hence, for the NP mechanism, aO/CF would be off-pathway aggregates that would 
slowly disassemble and serve as a steady source of monomers for RF growth until their complete 
disappearance (buffering). If aO/CF restructure into RF nuclei (NCC), then the RFs would 
further grow from either monomers or aO/CF, so the early stage aggregates get further 
restructured into nuclei, get incorporated into the RF (on-pathway), and/or decay (once the 
monomeric substrate gets depleted below the COC).  
An essential difference between NP and NCC scenarios for RF nucleation is the expected RFs 
nucleation lag period behavior below and above the COC. RF nucleation behavior has been 
shown to carry information about the amyloid aggregation molecular mechanisms
43,55,74,165,166
. At 
fixed nucleation and elongation rates, the lag period, τlag, follows a power law when is plotted 
against total protein concentration with a fixed scaling exponent for NP or NP with secondary 
nucleation (secondary nucleation: existing nuclei/RF can serve as catalytic surfaces for 
nucleation by lowering the energy barrier for new nuclei formation)
165,166
. Hence, for a fixed salt 
concentration below the COC, the RF τlag, should have a fixed scaling exponent, but as the 
HewL concentrations increase and aO/CF start to form rapidly, the τlag is expected to change 
depending on the RF nucleation mechanism. Distinguishing between the above RF nucleation 
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Figure 19. Schematic of Nucleated Conformational Conversion (NCC) vs. Nucleated 
Polymerization (NP) of Rigid Fibrils (RF). Aggregation kinetic curves and RF nucleation for a 
sample above the COC (top) In nucleated conformational conversion (NCC), partially denatured 
monomers first assemble into oligomers (aO) and curvilinear fibrils (CF). Either of these 
aggregates subsequently spontaneously re-structures into a critical nucleus (NCC nucleus 
formation marked by dotted line) that elongates into a rigid fibril (RF). Elongation might proceed 
via monomer or oligomer addition. The lag period for NCC arises from the low rates of aO/CF 
restructuring into an NCC nucleus (bottom) aO/CF and RF form independently/parallel to each 
other. RFs form via Nucleated Polymerization (NP) where partially denatured monomers (gray 
curve) assemble by chance encounter into a critical nucleus (NP nucleus formation marked by 
dotted vertical line). This nucleus subsequently grows via addition of partially unfolded 
monomers into a rigid fibril (RF). The lag period in NP is associated with the low probability of 
forming the initial nucleus. Notice that kinetics alone would not be able to discern between these 
two scenarios. 
 
lag periods behavior can be directly tested using the phase diagram: at a fixed salt concentration 
and increase in protein concentration leads to an increase in the amounts of aOs/CF being formed 
(fig. 14, fig. 17b). 
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Figure 20. Schematic of Anticipated Changes in Rigid Fibrils Lag Period Upon Crossing of 
Critical Oligomer Concentration for Nucleated Polymerization (NP), Nucleated 
Conformational Conversion (NCC) and Nucleated Polymerization (NP) with aO Buffering. 
Notice the same RF lag period scaling exponent for NP in absence of any aO/CF (middle straight 
line across the COC). RF lag period is expected to decrease as aO/CF is increased. RF lag period 
in presence of off-pathway aO/CF is expected to drop slightly in vicinity of COC following the 
pure NP scaling behavior, but eventually coming to the value for RF lag period at COC. 
 
In case RF nucleate via a random encounter of monomers (NP) in presence of aO/CF (off-
pathway aggregates), the RF τlag is expected to follow the pure NP behavior in the vicinity of 
COC since the driving force for aO/CF is relatively modest, and the effective total monomer 
concentration is not changing during the RF τlag. As the total protein concentration increases, the 
driving force for aO/CF increases rapidly and the effective monomeric concentration decreases 
rapidly during the lag period and eventually reaches the COC values. Hence the RF τlag would 
asymptotically approach the RF τlag at COC monomeric concentration as the total monomeric 
concentration increases (fig. 20). 
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If RF nucleate via internal restructuring of aO/CF (NCC), then the probability of forming a 
nucleus is strongly dependent on aO/CF concentration. As aO/CF concentration increases, one 
would expect an increased probability of RF nucleation, hence a shortening in the RFs lag 
periods comparing to both pure NP and NP in presence of off-pathway aO/CF (fig. 20). Figure 
20 is a schematic of the expected behavior of lag periods for RF nucleation for the case of NP, 
NP in presence of off-pathway aO/CF and NCC across the COC.  
(a) 
 
(b) 
 
Figure 21. Lag Periods for Rigid Fibrils Nucleation below and above the Critical Oligomer 
Concentration. (a) Semi-log plot of HewL amyloid nucleation and growth kinetics just below 
(orange) and above (purple) the COC for samples incubated at pH 2, T = 52 °C, 450 mM NaCl 
and at the indicated HewL concentrations. The semi-logarithmic display highlights the aO/CF 
kinetics at the expense of the large ThT response following RF nucleation (b) Measured lag 
period as a function of HewL monomer concentration, extracted from a series of kinetics 
measurements for the same set of solution and incubation conditions as shown in plot (a). 
 
Since the COC delineates a sharp boundary, one can measure the lag periods for RF nucleation 
below the COC and compare it to those for RF nucleation in the presence of aO/CF above the 
COC. This comparison allows one to establish if the presence of aO/CFs shortens the lag period 
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for RFs, strongly indicating that aO/CFs are on-pathway or assist (aO/CF surface serves as 
preferred nucleation site) RF nucleation. 
In figure 21a the experimentally measured ThT kinetic curves for a series of HewL 
concentrations are shown. These concentrations span protein concentrations from just below to 
well above the COC. Each kinetic curve represent the average from at least three sample s 
measured simultaneous in a plate reader, and are consistent with earlier observations
49,138
. The 
semi-log display of the ThT kinetics is used to highlight the transition in growth kinetics. Just 
below and above the COC (50 µM for this specific salt concentration) the curves show similar 
RFs lag period. ThT fluorescence detects no aggregate formation below the COC at 35 µM 
HewL and a small initial slope at 70 µM indicates the formation of aOs. As the HewL 
concentration is increased, the initial slope rapidly increases and eventually, at 350 µM HewL, a 
clear plateau indicating the reach of COC can be seen. Surprisingly, instead of decreasing or 
reaching the value for HewL concentration at COC the lag periods for RFs nucleation slightly 
increases. Figure 21b summarizes the lag periods as a function of initial protein concentrations 
for the same NaCl concentration as in figure 21b, but for a wide protein concentration span. It is 
easy to notice that RFs lag periods in the vicinity of the COC are similar within experimental 
error, but increase as the protein concentration is increased. The lack of shortening RF τlag in 
presence of aO/CF is good evidence that NP is the molecular mechanism of RFs nucleation on 
both sides of the COC.  
We performed seeding experiments below the COC (fig. 22) as additional confirmation that 
HewL aO/CF are incapable of conversion into RFs on the time scale of spontaneous RF 
nucleation. By adding preformed aO/CF below the COC we also address the unlikely scenario 
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that we might have missed small populations of aO/CF already present below the COC which, in 
turn, might dominate nucleation rates below the COC.  
 
 
 
 
 
 
Figure 22. Lag Periods for Rigid 
Fibrils Nucleation upon “Seeding” 
with Oligomers and Curvilinear 
Fibrils below the Critical Oligomer 
Concentration 
Semi-log plot of HewL RF nucleation 
and growth kinetics below the COC 
(3.8 µM HewL, 400 mM NaCl) 
without seeding (control) or after 
seeding with isolated aO/CF (purple) 
or RF (orange) 
  
As shown in figure 22, controls without addition of seeds undergo nucleated polymerization. 
Similarly addition of preformed and isolated RFs eliminates the lag period and induces 
immediate fibril elongation. In contrast, addition of isolated aO /CFs below the COC induces a 
detectable increase in ThT response indicating that those concentrations are now well above any 
potential level of ―contaminating‖ oligomers we might not have picked up. As expected, below 
the COC, the aO/CF undergo a slow decay. Yet, despite these highly elevated levels of aO/CF, 
the lag period for RF nucleation, yet again, slightly increases, just as observed in the presence of 
aO/CF above the COC. This confirms that aO/CF under all conditions do not undergo structural 
conversion into RFs on a time scale competitive with NP of RF. 
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V. DISCUSSIONS AND CONCLUSIONS 
 
 Extracellular depositions of insoluble amyloid fibrils are the pathological hallmark of a 
group of diseases called amyloidoses. Alzheimer, Parkinson and type II diabetes are just a few 
examples of amyloidoses which are affecting millions of people worldwide. Regardless of the 
protein of origin, amyloid fibrils have a set of structural characteristics that distinguish them as a 
group. Usually, these are long, straight unbranched proteinaceous fibrils that have a cross-β sheet 
core easily recognizable by its X-ray diffraction pattern with a sharp reflection at 4.7 Å along the 
fibril direction and a less sharp reflection at 10–11 Å perpendicular to the fibril direction. This 
cross-β sheet motif is commonly recognized by the benzothiazole dye Thioflavin T (ThT) and, 
when stained with Congo Red, exhibits birefringenceunder cross polarized light. Both in vitro 
and in vivo experiments have shown that amyloid fibril formation can proceed via different 
assembly pathways one of which involves early stage soluble intermediates called oligomers. 
These early stage oligomers are considered the main culprit of amyloidosis since they have been 
shown to be the most toxic amyloid species. Despite significant efforts, the relationship between 
the early stage oligomers and their late stage fibril has remained unclear. There are currently two 
dominant hypotheses of how early-stage oligomers are supplanted at late stage by the rigid, 
amyloid fibrils. One model suggests that early stage aggregates are off-pathway but kinetically 
favored, with long rigid amyloid fibrils formed via nucleated polymerization (NP) from 
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monomers, and independently from off-pathway oligomers. The other model proposes that early 
stage oligomers are on pathway, kinetically favored pre-cursors of rigid fibrils that can undergo 
internal restructuring to form the nuclei for rigid fibrils. There have been reports supporting 
either mechanism based on data from various amyloid and prion proteins. Yet direct evidence for 
one mechanism or the other is missing. This is due, in part, to a lack of a coherent overview of 
all the types of amyloid aggregates and their structure that are accessible to a system under well-
defined growth conditions. In addition, both the kinetics and morphological evolution of fibril 
formation following either mechanism are qualitatively indistinguishable.  
In 2011, our lab identified and characterized the distinct aggregate populations formed by Hen 
Egg White Lysozyme, an amyloid forming protein, under denaturing conditions (low pH, high 
temperature). Depending on the ionic strength, HewL either formed long straight fibrils, well-
defined globular oligomeric species that further polymerize into curvilinear fibrils, or amorphous 
aggregates
52
. Each self-assembly pathway had characteristic Static Light Scattering (SLS) 
kinetics signatures and distinct aggregate populations observed with Dynamic Light Scattering 
(DLS) and Atomic Forces Microscopy (AFM). In 2013, using ThT and Fourier Transform 
Infrared Spectroscopy (FTIR) as structural probes, we reported that both long rigid fibrils and 
oligomeric species display features indicative of their underlying amyloid structures. ThT also 
indicated that polymerization of oligomers into curvilinear fibrils proceeds without significant 
restructuring of oligomers. Hence oligomers and curvilinear fibrils represent amyloid species 
distinct from rigid fibrils. We also showed that ThT has orders of magnitude higher affinity for 
rigid fibrils than for oligomeric species, and that ThT responses closely matched the SLS kinetics 
signature.  
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One of my research objectives was to map out the protein- and salt-concentration phase space for 
amyloid fibril formation under conditions of fixed pH and incubation temperature. Specifically I 
set out to determine the combinations of protein and salt concentrations that resulted in the 
growth of either rigid fibrils or the formation of oligomers and curvilinear fibrils. Towards that 
end, I used aggregation kinetics, spectroscopy and high-resolution imaging to ascertain which 
type of amyloid aggregates had emerged. This kinetic phase diagram of amyloid assembly 
spanned HewL concentrations from 6 μM to 1.4 mM and NaCl concentrations from 50−800 mM. 
As outlined above in section III.3.3 my data indicate that long rigid fibrils (RF) are the 
thermodynamically stable state and they are the only aggregate state that can form in the low 
monomer/salt region of the phase diagram. Oligomers and their curvilinear fibrils (aO/CF), in 
turn, are the kinetically favored amyloid state at high monomer/salt concentrations of the phase 
space. The onset of oligomer formation is delineated by a sharp solubility boundary with strong 
similarities to the critical micelle concentration in surfactant solutions; hence we called this 
boundary the Critical Oligomer Concentration (COC). Equally important, I have shown that the 
oligomers/curvilinear fibrils represent a metastable phase; i.e., rigid fibrils seeded above the 
COC readily grew and eventually dissolved existing oligomers and curvilinear fibrils. I also 
mapped out the kinetic transition for the onset of precipitation at very high protein and/or salt 
concentrations. Our lab had previously considered these precipitates to be structureless 
amorphous aggregates. Using FTIR, I showed instead that these kinetically trapped aggregates 
already have the spectroscopic signatures characteristic of the amyloid oligomers formed at 
lower protein/salt concentrations. In collaboration with Dr. Jeremy Schmit from Kansas State, 
we established that the salt dependence of the COC was reproduced with surprising accuracy 
using a simplified colloidal model of charge effects on amyloid oligomer stability. With 
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additional modifications, Dr. Schmit could extend this model further to reproduce the transition 
to the kinetically trapped precipitates.  
As noted in the introduction, one of the persistent questions in the field concerns the 
relation between early-stage amyloid oligomers and late-stage rigid fibrils. Are oligomers on-
pathway to rigid fibril formation (nucleated conformational conversion, NCC) or are they off-
pathway competitors to rigid fibril growth, with the latter emerging via nucleated 
polymerization? The above phase diagram gave us a unique tool to address this conundrum. 
Below the COC, i.e., in the region of the phase diagram where only RF can exist, RF form via 
nucleated polymerization. Above the COC, however, their presence in the late stages of 
aggregation could come about by either on-pathway NCC or independent NP. According to our 
kinetic measurement, above the COC, aO/CF form immediately upon incubation, thereby 
depleting the monomer substrate for RF nucleation via NP. Once the monomers are depleted 
down to the COC, the aO/CF driving force is zero and they stop growing. The RFs solubility, in 
contrast, is much lower. As a result they can nucleate and grow above and below the COC; 
however, the presence of different concentrations of aO/CF above the COC provides a unique 
way to distinguish between off-pathway nucleation of RFs from monomers vs. on-pathway 
nucleation from oligomers. If RF nucleation requires on-pathway oligomers, increasing 
concentrations of aO/CF should decrease the lag period, especially at high concentrations of 
oligomers. In contrast, the depletion of monomers by aO/CF down to the COC would buffer 
monomer concentrations and therefore clamp monomer concentrations available for RF 
nucleation to their value near the COC. As outlined above I tested these predictions by 
measuring the lag periods for RF nucleation below to well above the COC. These measurements 
provide good evidence that RF form via nucleated polymerization regardless of the presence of 
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aO/CF (see Section III.4.2). Moreover, ―seeding‖ with the metastable aO/CF below the COC did 
not decrease RFs lag period, which provided yet another strong hint that aO/CF are incapable of 
restructuring into RF nuclei (at least not in the time span of our kinetic measurements). 
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APPENDICES 
 
Appendix A. Critical Oligomer Concentration and Ppt Solubility Boundary  
  Theoretical Model  
 In the part a of the Appendix, I am giving the detailed description of the theoretical 
model of the cooperative COC transition presented earlier and being a part of the 2015 
Biomacromolecules article.  
A.1 Model of Colloidal Charge Repulsion Reproduces Critical Oligomer    
 Concentration Boundary 
 In order to replicate the ionic strength dependence of the COC, we developed a 
quantitative model of the electrostatic energy cost of confining charged monomers within the 
volume of an amyloid oligomer. Assuming rapid monomer-oligomer interconversion, the 
concentration of oligomers is related to the monomer concentration by an equation taking the 
form an n
th
 order reaction equilibrium; i.e., 
      
         (1) 
Here c1 and cn are the monomer and oligomer concentrations in mol/L, respectively, and Fn is the 
coalescence free energy of the oligomer discussed below. We chose n=8 for the number of 
monomers in an oligomer. This number is based on our previous experimental measurements of 
the narrow distribution of lysozyme oligomer volumes under these condition. This equation 
predicts a very sharp transition with the oligomer concentration rising as the 8
th
 power of the 
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monomer concentration (Fig A.1.1a). To define a critical oligomer concentration, we use the 
criterion that equal amounts of protein are in the monomer and oligomer states,   
     , which 
yields a critical concentration 
        
  
           
        
 (2) 
Given the steep dependence of cn on c1, the precise choice of definition for the phase boundary is 
not critical. We are interested in how the COC depends on salt concentration. We split the 
oligomerization free energy into two parts,               
   , where Fnon-ES is a non-
electrostatic contribution that is independent of salt concentration. The electrostatic term, 
   
          , is the difference in the electrostatic free energy between n like-charged 
monomers condensed into the volume of one oligomer vs. n widely separated monomers (see 
schematic in Fig. 6b). The critical concentration then takes the form 
                        (3) 
where A is a parameter obtained from fitting the experimentally measured COC. 
Fn and F1 are computed by approximating the protein and oligomer as charged spheres as 
described in the methods section. We do not expect that the simplifying assumption of a 
uniformly distributed surface charge significantly affects our results. First, the strong positive 
charge of lysozyme at pH 2 limits contributions from spatial variations in charge distribution. 
Secondly, more than half of the electrostatic contribution to the self-assembly energy comes 
from the distortion of their Debye screening layers. 
39
 This latter contribution is not sensitive to 
D. Finally, the 
product of actual oligomer assembly will have a high (8-fold) symmetry. The calculated COC‘s 
were fit to the experimental data using     
       
             as the only adjustable 
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parameter. The resulting model predictions of the COC are shown in Fig. 4 as a solid purple line 
through the experimental transition values. The model replicates the experimental values 
remarkably well despite the significant number of simplifying assumptions. Some minor 
systematic deviations are noticeable in the semi-log plot of the phase diagram for high salt and 
low protein concentrations. 
 
 
(a) 
 
 
(b) 
 
 
(c) 
 
 
 
Figure A.1. Colloidal Model for Critical Oligomer Concentration and Onset of Oligomer 
Precipitation (a) Plot of monomer and oligomer concentration vs. total protein concentration 
Ctot for a fixed salt concentration based on Eqn. (1). Notice the highly cooperative transition to 
oligomer formation with increasing Ctot which replicates the sharp COC boundary in our 
experimental data. The COC defined via c1 = n cn is close to the sharp upturn in cn (b) The 
colloidal model for amyloid oligomer formation (COC) considers a quasi-equilibrium between 
charged HEWL monomers and their oligomers (the color change from monomers to 
oligomers in this schematic does imply an underlying structural change). The model accounts 
for the salt-dependent cost in free energy of confining n monomers into an n-meric oligomer. 
Monomers and oligomers are surrounded by an orange cloud indicating the diffusive 
screening layer of salt ions. (c) Schematic of the colloidal model used to calculate the 
contributions of electrostatic repulsion of oligomers condensing into precipitates. The short 
range of the Debye layer compared to the size of the precipitates implies that the electrostatic 
contributions to the free energy are essentially the same for CFs and O-Ppts. This 
consideration, in turn, leads us to propose anisotropy in the attractive oligomer interactions as 
cause for the transition from ordered CF polymerization to precipitation. Figure adapted with 
permission from Miti et al., Biomacromolecules, 2015, 16 (1), pp 326–335, figure 6. 
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A.2 Loss of Colloidal Stability Predicts Onset of Oligomer Precipitation 
 We attempted to replicate the precipitation boundary using another colloidal model. We 
observed two distinct modes of supramolecular assembly above the COC: CF polymerization 
and oligomeric precipitation (PPt). Given the oligomeric structure of precipitates, this suggests 
that monomers must first coalesce into oligomers before they assemble into CFs or O-Ppt (Fig. 
A.1.1 b). As with RFs vs. oligomers above, the thermodynamically favorable CFs are kinetically 
disfavored due to their prolonged lag time while the O-Ppts appear immediately. The simplest 
model for the rapid appearance of precipitates would be a diffusion limited colloidal instability 
of the oligomers. In diffusion limited precipitation the resulting structures have a branched linear 
morphology with a fractal dimension of 1.8. 
47
 However, the Debye length at the salt 
concentrations where precipitates are observed is just a few angstroms. As a result, CFs and 
branched linear precipitates become energetically indistinguishable on the length scale of 
electrostatic interactions. Hence, the difference between these states must originate, instead, from 
the non-electrostatic binding interactions. Assuming anisotropic binding interactions where the 
oligomers are strongly interacting in the axial direction and weakly interacting along their radial 
direction could explain the reduced solubility of the CFs relative to the precipitates and their 
large persistence length relative to the Debye length. We recently postulated similar anisotropy 
of oligomer interactions in order to explain the prion-like self-replication of lysozyme oligomers 
under physiological solution conditions. Structural support for the polar vs. radial anisotropy of 
amyloid oligomer interactions is provided by the cylindrin structure reported for amyloid 
oligomers formed by model peptides.  
As with the oligomer phase boundary, we model the precipitation boundary as a quasi-
equilibrium between two states. The first state is a dilute solution of oligomers. If the 
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concentration of oligomers is cn, then the chemical potential in the solution phase is ln(cn). The 
second phase is the precipitate. The chemical potential in this state arises primarily from the 
energetics forming favorable oligomer-oligomer contacts and repulsive electrostatic interactions; 
i.e.,                  
     
. Here, Frad  is the free energy contribution from radial interactions 
and    
     
 is that due to electrostatic interactions. Since the timescales for precipitate formation 
preclude significant annealing, we assume that highly ordered polar contacts will be greatly 
suppressed compared to the weaker radial contacts. For this reason we are unable to extract a 
value for the polar binding energy. The polar binding energy determines the oligomer 
concentration required for the formation of CFs, which our experiments are unable to resolve 
from the oligomer formation boundary.  
There will also be an entropic contribution to the precipitate chemical potential due to the 
disordered nature of the precipitate. However, this contribution is a function of the precipitate 
density which we do not expect to vary over the salt concentrations of interest because of the 
short screening length. Therefore, the entropic contribution can be absorbed into the unknown 
parameter Frad. As a crude model, we assume that precipitates will appear when the chemical 
potential of the solution is greater than that of the precipitate. Therefore, the condition for the 
onset of precipitation is 
  n            
   
 (4) 
Since precipitation occurs when most of the protein is in the oligomer phase; i.e.,         , we 
find that precipitation occurs for 
     
       
     
 (5) 
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where          is a parameter that will be obtained by fitting. Since the electrostatic energies 
of linear assemblies and precipitates are essentially indistinguishable we used a cylinder 
geometry to calculate the electrostatic energy contributions to the free energy per molecule. 
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The resulting precipitation boundary is superimposed onto the experimental data in figure 4. 
Again, the theoretical prediction closely follows the experimental results.  
Our expressions for the COC and precipitation boundary contain two free parameters, A and B, 
which are related to the non-electrostatic contributions to the oligomerization and precipitation 
free energies. Since the electrostatic contributions are entirely repulsive, these terms will be 
dominated by cohesive forces like H-bonds or hydrophobic interactions. Upon fitting Eqn. 3 to 
the experimentally determined COC, we find A=4.3*10
-8
 corresponding to a non-electrostatic 
binding energy of -117 kT. This is partially offset by an electrostatic repulsion that ranges from 
84 kT to 37 kT as the salt concentration increases from 100 mM to 800 mM. Therefore, the net 
binding energy per protein varies between 4kT and 10 kT. For the precipitation fitting parameter 
in Eqn. 5 we find B = 2.0*10
-6
, which corresponds to Frad = -15.2 kT. With electrostatic 
repulsion included the net oligomer-oligomer binding energy varies from 8.9 kT (400mM salt) to 
11.4kT (800mM). This is comparable to the binding energy per monomer in the oligomer. 
Oligomer-oligomer contacts in the precipitate most likely involve multiple monomers interacting 
by less attractive surfaces. 
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Appendix B.  Methods Theoretical Background 
 In this section of the appendix, I give a detailed description of the physical principles 
behind the methods I used during my PhD work.  
 
B.1  Static and Dynamic Light Scattering Theoretical Background 
 Interaction of light with matter yields an abundant quantity of information regarding the 
structure and dynamics of a given system. Scattering, absorption and emission of 
electromagnetic waves by matter are the central physical phenomena studied in order to obtain 
information regarding a system of interest. The temporal and spatial resolution of obtained 
information depends on both, the physical state of the system and the physical parameters of the 
electromagnetic waves interacting with it
3
. Light scattering from small particles is omnipresent 
natural phenomena that is responsible for many visual effects like the blue color of the sky on a 
good day
4
 or the visualization of salt dissolving in water
5
. In the field of soft condensed mater, 
light scattering is of particular value due to its ability to give detailed information about the 
structure and nature of interactions of nano/mesoscopic particles in aqueous solutions. In the case 
of protein aggregation studies, light scattering methods reveal details about proteins‘ molecular 
weight in a monomeric state, oligomer/aggregate formation
6
, as well as protein aggregation 
kinetics
7 
. Light scattering measurements of proteins are ensemble measurements that rely on 
analysis of scattered light‘s intensity by the protein solutions. There are mainly two types of 
information obtained from light scattering measurements on protein solutions: time averaged 
intensity based information (or otherwise known as static light scattering, SLS) and time 
dependent intensity fluctuations based information (also known as dynamic light scattering, 
DLS) represented in figure 1. 
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Figure B.1. Static Light 
Scattering vs. Dynamic Light 
Scattering. SLS is based on 
intensity time average over ―long‖ 
time intervals (seconds), while 
DLS is based on short interval 
(milliseconds)intensity 
fluctuations. 
 
Static light scattering provides information about particles molecular weight, two/multi body 
interactions between the particles in solutions, and form factor of large particles (the former is 
valid if a multi-angle set up is used). As an electric field interacts with a given molecule, it 
dislocates the molecule‘s electrons towards one end of it, thus the electric field induces a dipole 
by polarizing the molecule. When this induced dipole relaxes, it emits the energy in form of a 
photon having the same wavelength (elastic scattering). This way, the physical picture of static 
light scattering is based on matter reacting to electromagnetic waves by polarizing itself. 
Polarizability represents the measure of electrons‘ shift within a given molecule in the direction 
of the applied field. The induced dipole‘s moment is directly proportional to both the applied 
field and the polarizability of the given molecule
8
 ,  
 ⃗  =    ⃡  ⃗  
Where    permittivity of vacuum is,  ⃡ is polarizability tensor and  ⃗  is the applied electric field. 
In the case of laser light scattering,  ⃗  is the electric field associated with the electromagnetic 
radiation, hence it has a defined polarization. Moreover, for Rayleigh regime of scattering, the 
particles in solution are much smaller than the wavelength of the incoming electric field (about 
λ/20), hence the polarizability can be considered constant. For particles in aqueous solution, the 
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solvent has a well-defined polarizability (also constant), hence the light scattering is given by the 
difference in polarizability of the solvent and the solute, otherwise known as excess 
polarizability,  
 ⃗  =   (                        ⃗  
Because the particles are much smaller than the wavelength of the electric field, each particle 
experiences a uniform oscillating electric field which induces at its turn an oscillating dipole. 
This oscillating dipole acts like an emitter of an isotropic electric field having the same 
wavelength as the incoming electric field, but slightly shifted phase. This phase difference can be 
neglected in Rayleigh regime for static light scattering.              
 ⃗  =    
      ⃗        
Where ω is 2πc/λ, is the angular frequency of light with wavelength λ,  ⃗  is the wave vector 
which indicates the direction the electromagnetic field‘s direction of propagation, | ⃗ |=2π/λ , 
and   is the position of interest, and    is the phase difference which is neglected. Hence, the 
time varying dipole moment becomes 
 ⃗  (t) =   (                          
      ⃗     =          
      ⃗     
The scattered electric field of an oscillating dipole electric field is then given by 
   = (
   
   
)
 
   
 =- 
         
   
       ⃗  ⃗   
where R = | ⃗ | is the distance from scattering volume to the detector. Usually, the scattering 
intensity is measured    =      
 .  
   =   
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For most SLS/DLS instruments, electric field is vertically polarized (z-axis) while the detector 
lays in the x-y plane, meaning that θ is  0 . Also, the scattered electric filed is independent of φ, 
since it is isotropic in the Rayleigh regime.  
Experimentally, the refractive index is easier to measure than polarizability, it is easier to 
express   , using
9
 
   
    
   
   
  
 , hence 
 
  
  
    =
   
 
 
   
  
    , and 
  
  
 = 
   
     
    
 
  
 
   
  
   
Where N is number density of particles in solution, M is the molecular weight of the particles, C 
is the mass density of the particles, NA is Avogadro‘s number, ε0 is the permittivity of vacuum, 
   is the refractive index of the scattering particles, and    is the refractive index of solvent. In 
case the density fluctuations of solvent can be neglected, it is easy to see that the scattering 
intensity depends on the particles‘ scattering power, mass concentration and osmotic pressure, 
     
    
 
 
  
     
 
Where T is temperature,    is Boltzman‘s constant, and   is osmotic pressure. From the 
equation above    is the scattering power for a particle and also known as optical contrast factor 
K  
K = 
   
  
  
 
  
 
   
  
   =    
 while osmotic pressure derived based on fluctuation theory developed by Smoluchowski and 
Eistein
10
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    = 
   
 
   for ideal solution, where there is no inter-particle interactions,  
                  
  
  
    =    
 
 
 2         for non-deal solutions, with Bn being the virial 
coefficients. 
Scattering intensity also depends on the geometry of the SLS/DLS apparatus. The wavelength of 
the laser used, the distance between the detector, the scattering sample and the scattering volume 
are the main parameters that affect the scattering intensity. Introducing the Rayleigh ratio is a 
natural way of accounting for the experimental set-up as well as for any angular dependencies 
that have been neglected based on particles size assumption. For a multiangle set-up, this ratio 
has to be measured and calculated for every angle.  
   = (      )
 
  
 = (      )
       
    
 
Where      and          are the scattering of a standard and the normalized, tabulated scattering 
of the standard (usually toluene). Combining together the expressions for scattering intensity and 
Rayleigh ratio, it is possible to get an expression that can be directly used in the laboratory to 
extract molecular weight and the virial coefficient that describes the two-body interactions of 
particles in solution. 
  
  
 = 
 
 
 + 2  C +… 
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Figure B.2. Static Light Scattering and Dynamic Light Scattering Experimental Diagram. 
Light from a laser passes through a solution and the scattered light‘s intensity is measured at 
different angles in the plane perpendicular to the initial light‘s polarization. A computer equipped 
is calculating the correlation function in real time. 
 
Dynamic light scattering is mainly used to obtain particles diffusion coefficients, as well as 
correlation relaxation times in some systems, like protein gels.  
Given that in solutions particles are subject to Brownian motion, it is possible to measure 
indirectly the particles sizes in solution through the diffusion coefficient. The diffusion 
coefficient measured in DLS experiments is linked to the hydrodynamic radius through Stokes 
equation of a diffusing sphere with radius    in a solution with viscosity η, at temperature T11 
D 
   
    
. 
The hydrodynamic radius is related to the measured diffusion coefficient by the Stokes-Einstein 
equation, 
  = 
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In reality, the Stokes-Einstein has a general form that is dependent on protein concentration in 
solution and its generalized form is given by              
  = 
 
   
 
  
  
    
Where D is the diffusion coefficient, M is the molecular weight, f is the friction coefficient, C is 
the mass density of the particles, NA is Avogadro‘s number, and   is osmotic pressure. Here the 
expression becomes more complicated, since both the diffusion coefficient and the friction 
coefficient are concentration dependent  
       1       ); 
       1        
where the superscript ―0‖ indicates the values at zero protein concentration. So together with the 
expansion for the osmotic pressure given previously, and the fact that     2         
and that by definition    = 
  
    
 the diffusion coefficient becomes  
             
             
            
 = 
                   
    
 =    1   2             
As it can be seen from the equation above, in order to obtain  , one must perform DLS 
measurements for a series of concentrations, and then extrapolate to zero concentration. It is easy 
to see that the interaction parameter    is obtained from static light scattering, and is then used to 
calculate  , and obtain the real diffusion coefficient. 
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B.2 Thiovlavin T Fluorescence Theoretical Background 
 In 1959 Vassar and Culling showed that the benzathiole derived dyes Thioflavin T and S 
(ThT/ThS) have the greatest affinity for amyloid plaques and smaller number of false positives 
out of a large set of tested dyes, including Congo Red
12
. Later ThT was used to characterize 
amyloid fibrils purified from patients and it was reported that the dye undergoes a red shift in its 
excitation spectrum upon binding to amyloid fibrils from excitation and emission of 350 nm and 
438 nm respectively to 450 nm and 482 nm, and this shift was used to establish a linear 
relationship between the amount of amyloid fibril and ThT fluorescence for the first time
13–15
. 
Next, ThT was reported to be a great tool for monitoring amyloid fibril aggregation in vitro, and 
it became a valuable tool for monitoring amyloid fibril aggregation kinetics under a myriad of 
protein solution conditions
16,17
. 
Despite its wide use for monitoring amyloid fibrils aggregation, the mechanism and modes of 
ThT binding to the fibrils are still debated
16,18–24
. Early experimental works characterizing ThT 
spectral properties and first principle calculations have shown that ThT is a molecular rotor, 
displaying complex fluorescent behavior
25–29
. In a series of publications, Stiapura and his 
colleagues have shown that the electronic ground state of ThT, S0, corresponds to a 37
ᵒ 
angle 
between the C6 –C12 bond between the benzthiazole ring and benzene ring (φ in fig. 1a). Upon 
excitation, the first locally exited state (LE) starts at φ = 37ᵒ and relaxes to the minimum of the 
ThT exited singlet state, S1, with the dihedral angle of φ = 90 through internal charge-transfer 
(ICT). Upon spatial hindrance, both through high solvent viscosity or binding to rigid structures, 
the nonradiative twisted internal charge-transfer (TICT) state is obstructed and the molecule 
remains in the radiative locally exited state with φ close to 37ᵒ and relaxes through emissive 
radiation
 26,28,30
. 
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ThT binding to amyloid fibrils is still an active area of research and it has been shown that its 
binding modes are subject to specific fibril structure being mainly dictated by the steric and 
coulomb interactions with the amino acid residues of the fibril core
18–23,31
. The common theme 
emerging from the studies on ThT binding to amyloid fibrils is the ThT binding along the axis of 
the amyloid fibrils (its short axis perpendicular to the cross-β sheet‘ strands) in the 
grooves/channels created by amino acids residues of at least 5 β-strands18–20,24,31 (fig. 1b). 
(a) 
 
(b) 
 
 
 
Figure B.3. Thioflavin T Molecule. (a) chemical structure and molecular sizes
26
. Notice the two 
angles φ and ψ around the single bond that links the rigid structures of the molecule. Rotations 
around angle φ in the exited state correspond to either high or low quantum yield of ThT , while 
ψ angle‘s rotations have minimal effect (b) My artistic impression Thioflavin T molecule bound 
to the amyloid fibril core (based on text from references
18–20
). Part (a) of this figure is adapted 
with permission from Stiapura et al. Journal of Physical Chemistry A, 2007, 111, pages 4829-
4835, figure 1. 
There are various reports on ThT binding to amyloid fibrils either as micelle, dimer or individual 
molecules
21–23,32,33
. Recent works have shown that ThT binds in non-aggregated, monomeric 
form to HewL amyloid fibrils through a simple bimolecular mechanism
23,34
. Also, by means of 
microdialysis, Sulatskaya and her colleagues have identified that that there are two binding 
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modes of ThT to HewL amyloid fibrils at pH 2 Kb1 = 7.5* 10
-6
 M
-1
 and Kb2 = 5.6*10
-4
 M
-1
 with 
different number density of dye binding sites on the amyloid fibrils n1 = 0.11 and n2 = 0.24 
respectively
2
. 
 
B.3 Protein Fourier Transform Infrared Spectroscopy Theoretical Background  
 Mid infrared radiation absorption excites vibrational and rotational transitions of 
molecules. Vibrational transitions are forbidden unless there are also molecular dipole moment 
changes, hence the strength (type) and the polarity of the intramolecular bonds as well as 
coupling with other extramolecular effects have a strong influence on the absorption spectrum of 
a given molecule
36–40
.With the introduction of Fourier transform infrared spectroscopy (FTIR) 
and, especially attenuated total reflectance technique (ATR) for water based solvents, infrared 
spectroscopy became a valuable structural probe for protein research
40–42
. Vibrations of peptide 
bonds implicated protein secondary structure motifs give rise to nine IR bands with the Amide I 
band yielding the most reliable and easy to analyze data
38,42–44
. The frequencies constituting 
amide I band (1700 – 1600 cm-1) depend on stretching of C=O bonds and N-H of peptide bonds 
(~80% and ~20% of its intensity respectively) and carry information about their 
microenvironments, hence the secondary structure to which they belong
36–39,45,46
. 
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(a) 
 
(b) 
Amide I Band Vibrational Modes 
Contributions 
 
Figure B.4. Near FTIR Spectrum and Main Vibrational Modes Contributing to IR Bands. 
(a) FTIR spectra of biopolymers. Notice the Amide I band and its regions in the insert
47
 (b) 
vibrations modes responsible for amide I absorbance band. C=O stretching has the biggest 
contribution and N-H stretching has the second highest contribution
167,168
.  
In a series of three papers in 1976 Chirgadze and Nevskaya have calculated and confirmed in 
experiments the peaks of the two main structural motifs α-helix and β-sheets (parallel and anti-
parallel) based on analysis of pure α-helix and β-sheets formed by polyaminoacids.  
Table B.1. Amide I Band Assignment to Protein Secondary Structure Motifs Empirical vs. 
Theoretical Values. Notice the higher discrepancy between the empirical and theoretical values 
for α-helix. This discrepancy may arise from the experimental difficulty to have reliable data in 
that region of Amide I band due to the strong absorbance of water in the same exact region. 
  
Frequency (cm
-1
) Secondary Structure 
Associated 
Theoretical Value 
1620 - 1635  β-sheets 1627 (anti-parallel, weak)36,46 
1636 - 1643 β-sheets 1640 (parallel)46 
1644 - 1654  Random  - 
1654 - 1657 α-helix 1663
37 
1667 - 1685 β-turns 166548 
1689 - 1698  β-sheets 1690(anti-parallel, strong)38,39 
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Further additions and refinements from other groups described all secondary structural motifs 
within structurally complex proteins, and their respective bands have been assigned within the 
amide I region. A summary of these assigned bands is summarized in Table B.1
35–38,43–45
. 
Recently FTIR has started to be implemented as structural probe for identifying the 
intermolecular β-sheets of amyloid fibrils‘ core cross β-sheets which is shifted from the protein‘s 
native β-sheets49–55. Moreover, it has been shown that despite being a low resolution structural 
probe, FTIR is able to discern between amyloid fibrils‘ core cross β-sheets formed by the same 
protein under various solution conditions
50,54–56
.  
Table B.2. Comparison of Native vs. Amyloid Fibrils Core β-sheets. Notice that amyloid 
fibrils core β-sheets are emerge at lower frequencies than the native β-sheets for β2 
microglobulin and human lysozyme, and appear de novo for Aβ42 and α-synuclein also at low 
wavenumbers. 
Protein/Peptide Aggregate Species Low Wavenumbers β-
sheet Peak (cm
-1
) 
High Wavenumbers 
β-sheet Peak (cm-1) 
Aβ42  Monomer (pH 7.4) - - 
Oligomer (pH 7.4) 1626
57
 1695
57
 
Fibrils (pH 7.4) 1620
57
 - 
α-synuclein Monomers (pH 7.4) - - 
Oligomers (pH 7.4) 1625
58,59
 1695
58,59
 
Fibrils (pH 7.4) 1628
58,59
 - 
β2 microglobulin Monomers (pH 7.5) 1633
60
 - 
Oligomers (pH 2.1) 1618
60
 1684
60
 
Fibrils (pH 2.1) 1620
60
 - 
Human Lysozyme Monomers (pH 3) 1632
62
 - 
Oligomers (pH 3) 1630
62
 1688
62
 
Fibrils (pH7) 1626
55
 1693
55 
Fibrils (pH 2) 1622
35,55,61
 - 
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A summary of most commonly studied amyloidogenic proteins/peptides comparison of native 
and amyloid core β-sheets is summarized above in table B.255,57–62. 
 
B.4 Atomic Force Microscopy Theoretical Background 
 Since its introduction by Binnig, Quate and Gerber in 1986, Atomic Force Miscroscopy 
(AFM) has been an invaluable tool for getting high resolution topological images of 
nonconductive materials
63,64
. The introduction of the flexible cantilever with optical heterodyne 
detection of the cantilever vibrations converted AFM into a high resolution (sub 100 Å), high 
quality, single molecule technique
65
. In recent decades, AFM has become a highly employed 
method for studying mature amyloid fibril morphologies as well as their temporal evolution from 
pre-fibrillar aggregates to end stages
7,66–70
. 
A general operation diagram of an AFM is given in figure 1a. As one can notice, there are three 
main components in the construction of an AFM: piezoelectric transducers, force transducers and 
feedback control loop. The force transducers measure the force between the tip (figure B.4.1b) 
and the sample; the piezoelectric transducers move the AFM tip over the sample; the feedback 
control loops the signal from the force transducer back in to the piezoelectric in order to keep a 
constant force between the tip and the sample, or a fixed deflection of the cantilever depending 
on the AFM scanning mode
64
. Usually, the force transducer in an AFM is a cantilever with 
integrated tip (the probe), and an optical lever (see fig. B.4.1b). During a measurement a laser 
beam is reflected by the back reflective surface of the cantilever into a four-segmented 
(quadrupole) photodetector. The reflected light‘s path changes when the tip at the end of the 
cantilever interacts with the sample. This change is detected by the photodetector and the sensed 
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force is used by the feedback controller to set the z peizo‘s position (fig. B.4.1). Force 
transducers are conventionally made of amorphous lead barium titanate (PdBaTiO3) or lead 
zirconate titanate (Pb[ZrxTi1-x]O3, or PZT). They are 50 – 300 µM long and 20 – 60 µM long 
and 0.2 – 1 µM thick. Modern commercial AFMs use piezoelectric materials that can undergo 
changes as low as 0.1 nm per volt applied and force transducers are capable of measuring forces 
lower than 10 pN. For non-contact imaging, more often the cantilevers are made of silicone 
nitride (Si3N4) while the probe itself is made of silicone and are much stiffer than the cantilever. 
(a) 
 
 
 
Figure B.5. AFM Construction and 
Working Principles. (a) Block-
diagram of AFM operation based on 
reference 62 text description Notice the 
three main components of an AFM: the 
force transducer which is also the 
cantilever, the piezoelectric crystals 
responsible for independent movement 
in any of the x,y,z directions and the 
feedback electronic controller (b) 
Designs for tip‐scanning AFM with 
optical lever sensors based reference 62 
text descriptions. Notice how the 
movements of the tip due to its 
interaction with the sample translate 
into the movement of the cantilever. 
The laser light reflecting of the 
reflective surface on the back of the 
cantilever is detected by the 
photodetector. Any change in the 
light‘s path due to movements of the 
cantilever is registered by one of the 
four poles of the detector and is 
translated into a voltage applied to the 
PZT in order to regulate the force 
(distance) between the sample and the 
probe. 
(b) 
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One of the main factors/limitations of AFM image quality is the geometry and the dimension of 
the probe
64,71,72. The image taken (the measured sample‘s profile) with AFM is an actual 
convolution between the sample shape and the probe‘s geometry (figure B.4.2a). This way, while 
the height in AFM images is given reliably, the widths are distorted resulting in much wider xy 
dimensions (fig. B.4.2b). If the geometry of the probe is given by the manufacturer or is 
measured using standards (usually 100 nm spheres), the images can be deconvoluted and the real 
widths of imaged samples can be determined
7,64,72
. 
(a) 
 
(b) 
 
Figure B.6. Image Distortions Introduces by the AFM Tip. (a) Effect of the geometry and 
size of the AFM probe on the measured profile
72
. Notice how the diameter of the tip itself as well 
as the tip‘s end affect the sample‘s measured profile (b) Distortion of a spherical bead imaged 
with a circular tip
71
. Notice that the apparent width of a sample would be twice its actual value 
even if the tip‘s end diameter is only half the diameter of the measured sample itself. Part (a) of 
this picture is adapted with permission form Marinello at al., J. Manuf. Sci. Eng., 2010, 132, 
030903, figure 4. Part (b) of this picture is adapted from 
http://experimentationlab.berkeley.edu/sites/default/files/AFMImages/Lecture_10_AFM.pdf.  
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B.5 Circular Dichroism Spectroscopy Theoretical Background 
 Circular dichroism spectroscopy (CD) is a great tool for probing proteins secondary and 
tertiary structure
73,74
. This method is based on absorbance by a molecule of preferably left or 
right polarized light. As a result of preferably absorbing clockwise or counter clockwise rotating 
light at a specific wavelength, the addition of electric filed vectors after passing though the 
sample traces an ellipse rather than a circle. This deviation from a perfect circularly polarized 
light is called ellipticity and is measured in degrees (in biomolecules is of order of 
milidegrees)
73
.  
 
 
 
 
Figure B.7. Far-UV CD spectra of 
the main secondary structures motifs 
in a protein. Notice the α- helix 
negative peaks at 208 nm and 222 nm 
and positive at 193 nm; the β-sheets 
negative peak at 218 nm and positive 
peak at 195 nm; low ellipticity at 210 
nm and the negative peak at 195 nm of 
disordered motif (coil). adapted from 
http://www.fbs.leeds.ac.uk/facilities/cd/ 
Molecules that possess an intrinsic chirality or are placed in a chiral surrounding would manifest 
circular dichroism. In a protein peptide bond is the main absorber, hence its environment would 
modify the extent and type of polarized light it absorbs making it an excellent probe for 
identifying the presence and (to some extent) percent of different secondary structure motifs
73–75. 
Notice the α- helix negative peaks at 208 nm and 222 nm and positive at 193 nm; the β-sheets 
negative peak at 218 nm and positive peak at 195 nm; low ellipticity at 210 nm and the negative 
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peak at 195 nm of disordered motif (coil). Spectrum of a complex protein is a linear combination 
of the spectra for individual structural motifs in proportion to their presence in the protein. 
B.6 Gel Electrophoresis Theoretical Background 
 Gel electrophoresis is a great method of separating biopolymers based on their molecular 
weight. Since its introduction by Smithies in 1955 it became a central method for separating and 
identifying proteins complexes into components as well as identifying any changes to them that 
would affect their molecular weight including chemical or aggregation
58,59,76–79
. 
Gel electrophoresis is based on migration of electrically charged biopolymers embedded in a 
(usually) polyacrylamide matrix under the influence of an electric field
76
. The matrix pores 
determine the maximum molecular weight that can migrate as well as the resolution of the 
separation into individual bands; the higher the concentration of polyacrylamide, the smaller the 
pores within the matrix, hence smaller molecular weights can migrate and the resolution is 
better
79
. Also, for increased resolution additives that further decrease pore sizes (ex. ammonium 
persulfate) are added during the matrix preparation and those that help achieving band better 
resolution are added in the running buffer
77
. In SDS-Page electrophoresis, proteins are first 
thermally denatured and then mixed with sodium dodecyl sulfate in order to charge uniformly all 
proteins, so that the migration in the electric field would be solely based on their molecular 
weight. β-mercaptoethanol is usually used to disrupt any disulfide bonds within the protein. 
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Life is an open access journal, so I can use figure 1 from Smith, J.E.; Mowles, A.K.; Mehta, 
A.K.; Lynn, D.G. Looked at Life from Both Sides Now. Life 2014, 4, 887-902   
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